<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article article-type="other"><?OLF?><?properties olf?><front><journal-meta><journal-id journal-id-type="nlm-ta">EMBO J</journal-id><journal-title>The EMBO Journal</journal-title><issn pub-type="ppub">0261-4189</issn><issn pub-type="epub">1460-2075</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pii">emboj2008196</article-id><article-id pub-id-type="doi">10.1038/emboj.2008.196</article-id><article-categories><subj-group subj-group-type="heading"><subject>New EMBO Member's Review</subject></subj-group></article-categories><title-group><article-title>IKK&#x003b1;, a critical regulator of epidermal differentiation and a suppressor of skin cancer</article-title><alt-title alt-title-type="short">IKK&#x003b1; and epidermal differentiation</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Descargues</surname><given-names>Pascal</given-names></name><xref ref-type="aff" rid="O1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sil</surname><given-names>Alok K</given-names></name><xref ref-type="aff" rid="O2">2</xref></contrib><contrib contrib-type="author"><name><surname>Karin</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="O1">1</xref><xref ref-type="corresp" rid="c1">a</xref></contrib><aff id="O1"><label>1</label>Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, Cancer Center, School of Medicine, University of California, San Diego, La Jolla, CA, USA</aff><aff id="O2"><label>2</label>Department of Microbiology, University of Calcutta, Kolkata, West Bengal, India</aff></contrib-group><author-notes><corresp id="c1"><label>a</label>Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, Cancer Center, School of Medicine, University of California, San Diego, 9500 Gilman Drive, MC 0723, La Jolla, CA 92093-0723, USA. Tel.: +1 858 534 1361; Fax: +1 858 534 8158; E-mail: <email>karinoffice@ucsd.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>09</month><year>2008</year></pub-date><fpage/><lpage/><history><date date-type="received"><day>9</day><month>07</month><year>2008</year></date><date date-type="accepted"><day>3</day><month>09</month><year>2008</year></date></history><copyright-statement>Copyright &#x000a9; 2008, European Molecular Biology Organization</copyright-statement><copyright-year>2008</copyright-year><permissions><license license-type="open-access" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This licence does not permit commercial exploitation or the creation of derivative works without specific permission.</p><!--author-paid--></license></permissions><abstract><p>I&#x003ba;B kinase &#x003b1; (IKK&#x003b1;), one of the two catalytic subunits of the IKK complex involved in nuclear factor &#x003ba;B (NF-&#x003ba;B) activation, also functions as a molecular switch that controls epidermal differentiation. This unexpected function requires IKK&#x003b1; nuclear translocation but does not depend on its kinase activity, and is independent of NF-&#x003ba;B signalling. <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> mice present with a hyperproliferative and undifferentiated epidermis characterized by complete absence of a granular layer and <italic>stratum corneum</italic>. <italic>Ikk</italic>&#x003b1;-deficient keratinocytes do not express terminal differentiation markers and continue to proliferate even when subjected to differentiation-inducing stimuli. This antiproliferative function of IKK&#x003b1; is also important for the suppression of squamous cell carcinogenesis. The exact mechanisms by which nuclear IKK&#x003b1; controls keratinocyte proliferation and differentiation remained mysterious for some time. Recent studies, however, have revealed that IKK&#x003b1; is a major cofactor in a TGF&#x003b2;&#x02013;Smad2/3 signalling pathway that is Smad4 independent. This pathway controls cell cycle withdrawal during keratinocyte terminal differentiation. Although these are not the only functions of nuclear IKK&#x003b1;, this multifunctional protein is a key regulator of keratinocyte and epidermal differentiation and a critical suppressor of skin cancer.</p></abstract><kwd-group><kwd>epidermal differentiation</kwd><kwd><italic>Ikk</italic>&#x003b1;</kwd><kwd>skin cancer</kwd><kwd>Smads</kwd><kwd>TGF&#x003b2;</kwd></kwd-group></article-meta></front><body><sec disp-level="1"><title>Introduction</title><p>The epidermis, the outermost part of the skin, is a stratified and keratinized squamous epithelium mainly composed of keratinocytes, which forms a protective barrier. Epidermal differentiation, which starts in the mouse at embryonic day (E) 12, leads to formation of several distinct cell layers characterized by their ultrastructure, mitotic state and expression of specific molecular markers (<xref ref-type="bibr" rid="b15">Fuchs and Byrne, 1994</xref>; <xref ref-type="bibr" rid="b34">Koster and Roop, 2007</xref>). The basal layer develops from the surface ectoderm at approximately E9.5 in the mouse. The <italic>p63</italic> gene, which specifies different isoforms of a transcription factor related to tumour suppressor p53, controls basal layer formation and maintenance as well as I&#x003ba;B kinase &#x003b1; (IKK&#x003b1;) expression (<xref ref-type="bibr" rid="b2">Candi <italic>et al</italic>, 2007</xref>; <xref ref-type="bibr" rid="b33">Koster <italic>et al</italic>, 2007</xref>). Basal keratinocytes, including epidermal stem cells and transit-amplifying cells, are cuboidal, express cytokeratins (CKs) 5 and 14 and have a high proliferative potential (<xref ref-type="bibr" rid="b34">Koster and Roop, 2007</xref>). These cells form the embryonic periderm (<xref ref-type="bibr" rid="b43">M'Boneko and Merker, 1988</xref>), which is lost on establishment of the epidermal barrier. At E12 in the mouse, the basal cells give rise to the intermediate cell layer located between the embryonic basal layer and the periderm (<xref ref-type="bibr" rid="b70">Smart, 1970</xref>; <xref ref-type="bibr" rid="b78">Weiss and Zelickson, 1975</xref>). The intermediate cells divide several times before they withdraw from cell cycle and mature into postmitotic spinous cells (<xref ref-type="bibr" rid="b70">Smart, 1970</xref>; <xref ref-type="bibr" rid="b34">Koster and Roop, 2007</xref>). By contrast, adult basal keratinocytes directly become spinous cells when terminal differentiation is initiated, without involvement of an intermediate cell type (<xref ref-type="bibr" rid="b34">Koster and Roop, 2007</xref>). The spinous layer is characterized by a switch in keratin expression, from CK5 and CK14 to CK1 and CK10 (<xref ref-type="bibr" rid="b16">Fuchs and Green, 1980</xref>). Involucrin, a marker of early terminal differentiation is also synthesized in the upper part of this layer. The spinous cells continue their differentiation and maturation to form the granular layer, which is characterized by keratohyalin granules and expression of the late differentiation markers loricrin and filaggrin (<xref ref-type="bibr" rid="b3">Candi <italic>et al</italic>, 2005</xref>). Terminal differentiation gives rise to the cornified layer (<italic>stratum corneum</italic>), which consists of extremely flat, keratin-filled and anucleated keratinocytes, called corneocytes, which are mummified within a lipid matrix (<xref ref-type="bibr" rid="b3">Candi <italic>et al</italic>, 2005</xref>; <xref ref-type="bibr" rid="b64">Segre, 2006</xref>). The <italic>stratum corneum</italic> is primarily responsible for the barrier function of the skin (<xref ref-type="bibr" rid="b11">Elias, 2004</xref>; <xref ref-type="bibr" rid="b64">Segre, 2006</xref>), which is established around E17.5 in mouse (<xref ref-type="bibr" rid="b23">Hardman <italic>et al</italic>, 1998</xref>). Although major progress has been made in understanding the molecular changes that characterize epidermal differentiation, less is known about the signalling pathways that control these events. Here, we provide an overview of the current understanding of the central function of IKK&#x003b1; in the control of epidermal differentiation, homoeostasis and tumorigenesis.</p></sec><sec disp-level="1"><title>Defective epidermal morphogenesis in <italic>Ikk</italic>&#x003b1;-deficient mice</title><p>The oligomeric IKK complex is composed of two catalytic subunits, IKK&#x003b1; and IKK&#x003b2; (<xref ref-type="bibr" rid="b9">DiDonato <italic>et al</italic>, 1997</xref>; <xref ref-type="bibr" rid="b47">Mercurio <italic>et al</italic>, 1997</xref>; <xref ref-type="bibr" rid="b81">Woronicz <italic>et al</italic>, 1997</xref>; <xref ref-type="bibr" rid="b86">Zandi <italic>et al</italic>, 1997</xref>), and a regulatory subunit named IKK&#x003b3; or NEMO (nuclear factor &#x003ba;B (NF-&#x003ba;B) essential modulator) (<xref ref-type="bibr" rid="b60">Rothwarf <italic>et al</italic>, 1998</xref>; <xref ref-type="bibr" rid="b82">Yamaoka <italic>et al</italic>, 1998</xref>). This complex is the key mediator of NF-&#x003ba;B activation in response to proinflammatory and innate immune challenges (<xref ref-type="bibr" rid="b60">Rothwarf <italic>et al</italic>, 1998</xref>). Although IKK&#x003b1; and IKK&#x003b2; share considerable sequence identity, it is IKK&#x003b2; that usually serves the more critical function in the activation of classical NF-&#x003ba;B signalling (<xref ref-type="bibr" rid="b72">Tanaka <italic>et al</italic>, 1999</xref>; <xref ref-type="bibr" rid="b40">Li <italic>et al</italic>, 1999b</xref>, <xref ref-type="bibr" rid="b41">1999c</xref>). To determine the unique functions of IKK&#x003b1;, several groups have disrupted the <italic>Ikk</italic>&#x003b1; locus in mice and were surprised to find that it has an essential function in epidermal differentiation and morphogenesis (<xref ref-type="bibr" rid="b28">Hu <italic>et al</italic>, 1999</xref>; <xref ref-type="bibr" rid="b39">Li <italic>et al</italic>, 1999a</xref>; <xref ref-type="bibr" rid="b71">Takeda <italic>et al</italic>, 1999</xref>). Newborn <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> mice present with multiple morphological defects, including shiny and translucent skin, absence of erupted whiskers, shortened limbs and truncated snout and tail (<xref ref-type="fig" rid="f1">Figure 1</xref>) (<xref ref-type="bibr" rid="b28">Hu <italic>et al</italic>, 1999</xref>; <xref ref-type="bibr" rid="b71">Takeda <italic>et al</italic>, 1999</xref>; <xref ref-type="bibr" rid="b85">Yoshida <italic>et al</italic>, 2000</xref>). These mice develop to term but die shortly after birth, probably as a consequence of a major skin barrier defect that results in severe dehydration.</p><p>The <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> epidermis is characterized by the presence of basal and suprabasal layers, both in a highly proliferative state, and complete absence of the granular and the cornified layers (<xref ref-type="fig" rid="f2">Figure 2A</xref>) (<xref ref-type="bibr" rid="b28">Hu <italic>et al</italic>, 1999</xref>; <xref ref-type="bibr" rid="b71">Takeda <italic>et al</italic>, 1999</xref>). At the molecular level, these anomalies are characterized by the expression of CK5 and CK14 as well as proliferating cell markers, such as CK6, PCNA (proliferating cell nuclear antigen) and Ki67 in basal and suprabasal layers (<xref ref-type="bibr" rid="b28">Hu <italic>et al</italic>, 1999</xref>; <xref ref-type="bibr" rid="b71">Takeda <italic>et al</italic>, 1999</xref>). In contrast, CK1 and CK10 are appropriately expressed in the first suprabasal layers of the <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> epidermis (<xref ref-type="bibr" rid="b28">Hu <italic>et al</italic>, 1999</xref>; <xref ref-type="bibr" rid="b71">Takeda <italic>et al</italic>, 1999</xref>). Involucrin is also synthesized in the upper part of the suprabasal layer of these mice (<xref ref-type="bibr" rid="b71">Takeda <italic>et al</italic>, 1999</xref>), indicating that an early step in the differentiation process still takes place, although late terminal differentiation markers, including loricrin and filaggrin, are not expressed (<xref ref-type="bibr" rid="b28">Hu <italic>et al</italic>, 1999</xref>; <xref ref-type="bibr" rid="b71">Takeda <italic>et al</italic>, 1999</xref>) (<xref ref-type="fig" rid="f2">Figure 2B</xref>). It was suggested that the highly proliferative suprabasal cells of the <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> epidermis, which express CK1 and CK10, are reminiscent of intermediate cells rather than spinous cells (<xref ref-type="bibr" rid="b34">Koster and Roop, 2007</xref>). Hence, the most critical function of IKK&#x003b1; may be induction of cell cycle exit needed for converting basal and intermediate keratinocytes to spinous cells. When this step fails, all subsequent differentiation states are aborted (<xref ref-type="fig" rid="f3">Figure 3</xref>).</p></sec><sec disp-level="1"><title>Nuclear IKK&#x003b1; controls terminal differentiation of keratinocytes</title><p>Control of epidermal proliferation and differentiation by IKK&#x003b1; does not involve its protein kinase function and is completely independent from NF-&#x003ba;B activation (<xref ref-type="bibr" rid="b29">Hu <italic>et al</italic>, 2001</xref>). <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> keratinocytes do not exhibit a primary defect in NF-&#x003ba;B activation (<xref ref-type="bibr" rid="b28">Hu <italic>et al</italic>, 1999</xref>; <xref ref-type="bibr" rid="b71">Takeda <italic>et al</italic>, 1999</xref>). In contrast, <italic>Ikk&#x003b1;</italic><sup>&#x02013;/&#x02013;</sup> keratinocytes display higher IKK and NF-&#x003ba;B activities than wild-type (WT) cells after incubation with either tumour necrosis factor-&#x003b1; or interleukin-1 (<xref ref-type="bibr" rid="b29">Hu <italic>et al</italic>, 2001</xref>). The observations that transgenic mice overexpressing a dominant inhibitor of NF-&#x003ba;B function (I&#x003ba;B&#x003b1;M) in the epidermis or mice lacking both RelA and c-Rel display epidermal hyperplasia that does not disrupt terminal differentiation and <italic>stratum corneum</italic> formation (<xref ref-type="bibr" rid="b65">Seitz <italic>et al</italic>, 1998</xref>; <xref ref-type="bibr" rid="b20">Gugasyan <italic>et al</italic>, 2004</xref>; <xref ref-type="bibr" rid="b87">Zhang <italic>et al</italic>, 2004</xref>), are consistent with the NF-&#x003ba;B-independent action of IKK&#x003b1; in the epidermis.</p><p>As observed <italic>in vivo</italic>, isolated <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> keratinocytes are hyperproliferative and do not respond to differentiation-inducing signals such as confluence or high Ca<sup>2&#x0002b;</sup> (<xref ref-type="bibr" rid="b28">Hu <italic>et al</italic>, 1999</xref>, <xref ref-type="bibr" rid="b29">2001</xref>). <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> keratinocytes, however, do differentiate <italic>in vitro</italic> when transduced by an adenovirus expressing a &#x02018;kinase-dead' form of IKK&#x003b1;, indicating that the kinase function is dispensable for keratinocyte differentiation (<xref ref-type="bibr" rid="b29">Hu <italic>et al</italic>, 2001</xref>). Instead, IKK&#x003b1; needs to enter the nucleus to induce keratinocyte cell cycle arrest and terminal differentiation (<xref ref-type="bibr" rid="b68">Sil <italic>et al</italic>, 2004</xref>). Nuclear entry depends on a nuclear localization sequence (NLS) within the IKK&#x003b1; kinase domain, the disruption of which prevents the induction of keratinocyte differentiation (<xref ref-type="bibr" rid="b68">Sil <italic>et al</italic>, 2004</xref>). An NLS is absent from IKK&#x003b2;, which cannot substitute for IKK&#x003b1; in keratinocyte differentiation and growth arrest. IKK&#x003b1; is also nuclear in basal and suprabasal cells of the epidermis (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>) and the oral epithelium (<xref ref-type="bibr" rid="b44">Maeda <italic>et al</italic>, 2007</xref>), findings that are consistent with the cell culture results.</p><p>The function of IKK&#x003b1; in the keratinocyte nucleus is linked to the production of a yet-to-be identified soluble factor or group of factors termed keratinocyte differentiation-inducing factor (kDIF) that can induce the expression of terminal differentiation markers, even in <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> cells (<xref ref-type="bibr" rid="b29">Hu <italic>et al</italic>, 2001</xref>). Consistent with the existence of kDIF, transplantation of <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> skin onto the back of immuodeficient WT mice allows the <italic>Ikk</italic>&#x003b1;-deficient epidermis to undergo normal differentiation, suggesting that the requirement for IKK&#x003b1; can be bypassed by factors produced by normal skin (<xref ref-type="bibr" rid="b29">Hu <italic>et al</italic>, 2001</xref>). These experiments do not exclude the possibility that another important source of kDIF or similarly acting factors are dermal fibroblasts, which are well known to produce factors that control epidermal morphogenesis (<xref ref-type="bibr" rid="b80">Wessells, 1977</xref>). In support of this hypothesis, a keratinocyte-specific <italic>Ikk</italic>&#x003b1; disruption results in a less severe epidermal differentiation defect with altered skin barrier function than the total <italic>Ikk</italic>&#x003b1; knockout (<xref ref-type="bibr" rid="b17">Gareus <italic>et al</italic>, 2007</xref>). These results were interpreted to suggest that Ikk&#x003b1; functions non-autonomously in the dermis to control epidermal differentiation. However, <italic>Ikk</italic>&#x003b1;-deficient keratinocytes from the epidermal-specific knockout mouse still fail to differentiate <italic>in vitro</italic> (<xref ref-type="bibr" rid="b17">Gareus <italic>et al</italic>, 2007</xref>), similar to keratinocytes from total <italic>Ikk</italic>&#x003b1; knockout mice (<xref ref-type="bibr" rid="b29">Hu <italic>et al</italic>, 2001</xref>). Collectively, these results indicate that IKK&#x003b1; functions within epidermal keratinocytes and probably in dermal fibroblasts to induce keratinocyte differentiation. As keratinocyte-restricted expression of IKK&#x003b1;, unlike the keratinocyte-specific knockout, does not result in a differentiation defect (<xref ref-type="bibr" rid="b68">Sil <italic>et al</italic>, 2004</xref>), it appears that the keratinocyte is the major site of IKK&#x003b1; action with respect to keratinocyte differentiation and epidermal-directed morphogenetic events.</p></sec><sec disp-level="1"><title>IKK&#x003b1; is a critical component of a Smad4-independent TGF&#x003b2;&#x02013;Smad2/3 signalling pathway</title><p>The most immediate effect of IKK&#x003b1; re-expression in <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> keratinocytes is cell cycle withdrawal, which precedes the expression of differentiation markers (<xref ref-type="bibr" rid="b29">Hu <italic>et al</italic>, 2001</xref>). Thus, to understand the molecular function of IKK&#x003b1;, we searched for cell cycle-related target genes, the expression of which is IKK&#x003b1; dependent. This search netted several genes encoding negative cell cycle regulators, the expression of which is downregulated in <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> keratinocytes and epidermis, including <italic>Mad1</italic> and <italic>Ovol1</italic> (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>), which encode negative regulators of Myc. The <italic>c</italic>-<italic>Myc</italic> oncogene is thought to influence the balance between keratinocyte proliferation and differentiation, depending on the intensity and timing of its activity (<xref ref-type="bibr" rid="b76">Watt <italic>et al</italic>, 2008</xref>). Mad1 is a basic region/helix-loop-helix/leucine zipper transcriptional regulator that dimerizes with Max to form Mad:Max heterodimers that antagonize the transcriptional function of Myc:Max dimers (<xref ref-type="bibr" rid="b1">Ayer <italic>et al</italic>, 1993</xref>; <xref ref-type="bibr" rid="b19">Grandori <italic>et al</italic>, 2000</xref>). <italic>Mad1</italic><sup>&#x02013;/&#x02013;</sup> mice, however, are viable, phenotypically normal (<xref ref-type="bibr" rid="b14">Foley <italic>et al</italic>, 1998</xref>; <xref ref-type="bibr" rid="b19">Grandori <italic>et al</italic>, 2000</xref>) and do not show any epidermal defect. Most likely, other <italic>Mad</italic> genes, including <italic>Mad2</italic>, <italic>Mad3</italic> and <italic>Mad4</italic>, are functionally redundant with <italic>Mad1</italic> and compensate for its loss. Indeed <italic>Mad2</italic> and <italic>Mad3</italic> are also induced in keratinocytes in an IKK&#x003b1;-dependent manner (unpublished data). Ovol1 is a zinc-finger-containing transcription factor, which, similar to Mad1, is also expressed in differentiating suprabasal keratinocytes (<xref ref-type="bibr" rid="b5">Dai <italic>et al</italic>, 1998</xref>; <xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>). <italic>Ovol1</italic><sup>&#x02013;/&#x02013;</sup> adult mice present with aberrant hair formation but normal epidermal differentiation (<xref ref-type="bibr" rid="b5">Dai <italic>et al</italic>, 1998</xref>). However, the suprabasal epidermis of <italic>Ovol1</italic><sup>&#x02013;/&#x02013;</sup> embryos shows increased proliferation and <italic>in vitro</italic>, <italic>Ovol1</italic><sup>&#x02013;/&#x02013;</sup> keratinocytes fail to exit the cell cycle in response to growth-inhibitory signals, such as high Ca<sup>2&#x0002b;</sup> or TGF&#x003b2; (<xref ref-type="bibr" rid="b50">Nair <italic>et al</italic>, 2006</xref>). This defect may be explained in part by abnormal upregulation of <italic>c-Myc</italic>, which is a direct target of Ovol1 in keratinocytes (<xref ref-type="bibr" rid="b50">Nair <italic>et al</italic>, 2006</xref>). Thus, IKK&#x003b1; controls keratinocyte proliferation and cycling through the regulation of several Myc antagonists to allow keratinocytes to embark on their differentiation pathway (<xref ref-type="fig" rid="f4">Figure 4</xref>). Interestingly, another TGF&#x003b2;-related mechanism involving Smad3/4 and E2F4/5 transcription factors has been shown earlier to directly inhibit <italic>c-Myc</italic> expression in keratinocytes (<xref ref-type="bibr" rid="b4">Chen <italic>et al</italic>, 2002</xref>) (<xref ref-type="fig" rid="f4">Figure 4</xref>). Although this signalling pathway triggers antiproliferative effects of TGF&#x003b2; in keratinocytes, its impact on keratinocyte differentiation is unknown.</p><p>Mad1 and Ovol1 are involved in the inhibition of keratinocyte proliferation induced by TGF&#x003b2; family members (<xref ref-type="bibr" rid="b74">Vastrik <italic>et al</italic>, 1995</xref>; <xref ref-type="bibr" rid="b18">Gomis <italic>et al</italic>, 2006</xref>), suggesting a link between IKK&#x003b1; and the TGF&#x003b2; signalling pathway. TGF&#x003b2; family members, including TGF&#x003b2;s, activins and BMPs, are cytokines that control cell growth, differentiation and deposition of extracellular matrix through binding to heterodimeric cell surface receptor complexes composed of type I and II subunits, and intracellular Smad transcription factors (<xref ref-type="bibr" rid="b66">Shi and Massague, 2003</xref>; <xref ref-type="bibr" rid="b13">Feng and Derynck, 2005</xref>; <xref ref-type="bibr" rid="b63">Schmierer and Hill, 2007</xref>). The eight mammalian Smad proteins are divided into three distinct groups: receptor-activated Smads (R-Smads: Smad1, Smad2, Smad3, Smad5 and Smad8), a unique common Smad mediator (Co-Smads: Smad4) and inhibitory Smads (i-Smads: Smad6 and Smad7). On ligand binding, the type II receptor activates the type I receptor through its kinase domain, and the type I receptor in turn phosphorylates R-Smads. The activated R-Smads form heterodimeric complexes with Smad4, which accumulate in the nucleus and directly repress or activate specific target genes (<xref ref-type="bibr" rid="b66">Shi and Massague, 2003</xref>; <xref ref-type="bibr" rid="b13">Feng and Derynck, 2005</xref>; <xref ref-type="bibr" rid="b63">Schmierer and Hill, 2007</xref>).</p><p>TGF&#x003b2; family members, their receptors and Smad transcription factors are abundantly expressed in epidermal keratinocytes, suggesting homoeostatic and regulatory functions (<xref ref-type="bibr" rid="b24">He <italic>et al</italic>, 2001</xref>; <xref ref-type="bibr" rid="b35">Li <italic>et al</italic>, 2003</xref>). Phosphorylated Smad2 and Smad3 proteins are concentrated in the nuclei of basal and suprabasal keratinocytes, whereas nuclear Smad4 staining is more preeminent in basal cells (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>). Nonetheless, alterations of TGF&#x003b2; signalling in transgenic/knockout mice have often resulted only in minor epidermal defects, thereby obscuring its exact functions in this tissue (<xref ref-type="bibr" rid="b35">Li <italic>et al</italic>, 2003</xref>). We recently found that IKK&#x003b1; interacts strongly with Smad3 and weakly with Smad2, but does not bind Smad4 (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>). IKK&#x003b1; associates with the C-terminal MH2 domain of Smad3 through its kinase domain (unpublished observations). The R-Smad MH2 domain is known to be essential for <italic>trans</italic>-activation, phosphorylation by type I receptors and Smad4 binding (<xref ref-type="bibr" rid="b45">Massague, 2000</xref>; <xref ref-type="bibr" rid="b13">Feng and Derynck, 2005</xref>). On stimulation by TGF&#x003b2;1, IKK&#x003b1; and Smad3 form a transcriptional complex that accumulates in the keratinocyte nucleus to directly control the transcription of <italic>Mad1</italic> (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>). Similar findings were made for <italic>Ovol1</italic> (unpublished data). In <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> keratinocytes stimulated with TGF&#x003b2;1, Smad3 is no longer recruited to the <italic>Mad1</italic> regulatory region despite its normal association with Smad4. Furthermore, nuclear staining for activated Smad2 and Smad3 is dramatically diminished in the <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> epidermis (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>). Taken together, these results indicate that IKK&#x003b1; is required for nuclear accumulation and chromatin recruitment of phosphorylated Smad2 and Smad3 to IKK&#x003b1;-regulated genes in response to TGF&#x003b2;1. Interestingly, activin A, an important regulator of epidermal differentiation (<xref ref-type="bibr" rid="b54">Owens <italic>et al</italic>, 2008</xref>), is involved in the induction of <italic>Mad1</italic> expression in keratinocytes (<xref ref-type="bibr" rid="b79">Werner <italic>et al</italic>, 2001</xref>). As a result, one may speculate that the IKK&#x003b1;&#x02013;Smad2/3 complex forms and activates anti-Myc genes, including <italic>Mad1</italic>, on activin A signals. As activin A also downregulates the <italic>Id1</italic>, <italic>Id2</italic> and <italic>Id3</italic> genes in keratinocytes (<xref ref-type="bibr" rid="b61">Rotzer <italic>et al</italic>, 2006</xref>), it could also be interesting to analyse whether this signalling pathway depends on IKK&#x003b1;. Finally, we found that kDIF functions downstream of the IKK&#x003b1;&#x02013;Smad2/3 signalling pathway as it can induce differentiation of <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> keratinocytes without inducing <italic>Mad1</italic> expression (<xref ref-type="fig" rid="f5">Figure 5</xref>). Exactly how kDIF functions and what it is composed of remain to be determined.</p><p>The results mentioned above provided the first clear evidence for a critical function for Smad transcription factors in epidermal differentiation. Although Smad3 deficiency alone does not result in any cutaneous defect (<xref ref-type="bibr" rid="b89">Zhu <italic>et al</italic>, 1998</xref>; <xref ref-type="bibr" rid="b6">Datto <italic>et al</italic>, 1999</xref>; <xref ref-type="bibr" rid="b84">Yang <italic>et al</italic>, 1999</xref>) and the loss of Smad2 leads to early embryonic lethality (<xref ref-type="bibr" rid="b51">Nomura and Li, 1998</xref>; <xref ref-type="bibr" rid="b75">Waldrip <italic>et al</italic>, 1998</xref>; <xref ref-type="bibr" rid="b77">Weinstein <italic>et al</italic>, 1998</xref>; <xref ref-type="bibr" rid="b27">Heyer <italic>et al</italic>, 1999</xref>), loricrin and filaggrin expression is barely detectable in E15.5 embryos lacking both <italic>Smad3</italic> alleles and one <italic>Smad2</italic> allele in their epidermis (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>). Similarly, siRNA-mediated Smad2 knockdown in Smad3-deficient keratinocytes inhibited the expression of loricrin and filaggrin, as well as Mad1, in response to high Ca<sup>2&#x0002b;</sup> (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>). These results suggest that Smad2 and Smad3 are functionally redundant. The importance of the TGF&#x003b2;&#x02013;Smad2/3&#x02013;IKK&#x003b1; axis for proper epidermal differentiation is also underscored by the analysis of transgenic mice in which the i-Smad Smad7 is inducibly expressed in the epidermis, resulting in defective expression of loricrin and filaggrin and failed <italic>stratum corneum</italic> formation (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>). Consequently, these mutant mice display epidermal hyperplasia due to abnormal proliferation of suprabasal keratinocytes and loss of nuclear IKK&#x003b1; and Mad1 (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>).</p><p>Surprisingly, this new TGF&#x003b2; response pathway centred around Smad2/3&#x02013;IKK&#x003b1; complex formation is independent of Smad4. Smad4-deficient keratinocytes display normal Mad1 expression (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>) and undergo terminal differentiation in response to high Ca<sup>2&#x0002b;</sup> (unpublished data). These results are consistent with the phenotype of mice with epidermal-specific deletion of <italic>Smad4</italic> (<italic>Smad4</italic><sup>&#x00394;/&#x00394;</sup> mice). These mice present with degeneration of hair follicles and dermal cysts that progress to skin tumours in old animals, but do not show any perturbated epidermal differentiation and <italic>stratum corneum</italic> formation (<xref ref-type="bibr" rid="b83">Yang <italic>et al</italic>, 2005</xref>; <xref ref-type="bibr" rid="b56">Qiao <italic>et al</italic>, 2006</xref>). Furthermore, activated Smad2 and Smad3, as well as IKK&#x003b1;, are normally localized in the nuclei of <italic>Smad4</italic><sup>&#x00394;/&#x00394;</sup> keratinocytes, which display normal Mad1 expression (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>). Taken together, these results strongly indicate that Smad4 is not required for epidermal differentiation. The Smad4 independence of the TGF&#x003b2;&#x02013;Smad2/3&#x02013;IKK&#x003b1; signalling pathway is reminiscent of another TGF&#x003b2; signalling operative during erythroid development in which TIF1&#x003b3; (also called TRIM33 or ectodermin) replaces Smad4 (<xref ref-type="bibr" rid="b25">He <italic>et al</italic>, 2006</xref>). However, TIF1&#x003b3; is a RING-type ubiquitin ligase that can target Smad4 to degradation and can therefore function as a negative regulator of Smad4-dependent TGF&#x003b2; signalling (<xref ref-type="bibr" rid="b10">Dupont <italic>et al</italic>, 2005</xref>). Hence the exact function of TIF1&#x003b3; in TGF&#x003b2; signalling is not fully understood, and it is not known whether it affects the IKK&#x003b1;-dependent pathway.</p></sec><sec disp-level="1"><title>IKK&#x003b1; and squamous cell carcinoma</title><p>IKK&#x003b1; was recently identified as a tumour suppressor in squamous cell carcinoma (SCC) (<xref ref-type="bibr" rid="b42">Liu <italic>et al</italic>, 2006</xref>; <xref ref-type="bibr" rid="b44">Maeda <italic>et al</italic>, 2007</xref>). SCC is a cancer derived from squamous epithelia of the skin (epidermis), head and neck tissues (mouth, throat, oral and nasal cavities, esophagus) as well as other sites. SCC is the second most common skin cancer in Caucasians with an estimated incidence of 100 000&#x02013;150 000 new cases per year in the United States (<xref ref-type="bibr" rid="b31">Johnson <italic>et al</italic>, 1992</xref>). Sun exposure and immune suppression increase the risk of SCC development and so does tobacco use (<xref ref-type="bibr" rid="b62">Rudolph and Zelac, 2004</xref>; <xref ref-type="bibr" rid="b21">Hampton, 2005</xref>). SCC of the oral cavity is one of the most prevalent cancers of the head and neck region with a worldwide incidence of 300 000 new cases per year, the occurrence of which is linked to tobacco use and betel nut chewing (<xref ref-type="bibr" rid="b69">Silverman, 2001</xref>). SCCs of the oral cavity are more aggressive than those developing from the skin, and are associated with a 5-year survival rate of about 50&#x02013;55&#x00025; (<xref ref-type="bibr" rid="b69">Silverman, 2001</xref>).</p><p>Molecular changes in SCCs are characterized by a marked heterogeneity and include activation of oncogenes, such as <italic>RAS</italic>, <italic>MYC</italic>, <italic>EGFR</italic> and <italic>Cyclin D1</italic>, as well inactivation of tumour suppressors, including <italic>p53</italic> and <italic>p16</italic> (<xref ref-type="bibr" rid="b22">Hardisson, 2003</xref>). These genetic alterations are thought to influence malignant keratinocyte behaviour and tumour progression, but the precise molecular pathogenesis of SCC is poorly understood. Interestingly, mutations in exon 15 of the <italic>IKK</italic>&#x003b1; locus were described in a few high-grade and poorly differentiated human SCCs of the skin and were shown to be associated with reduced <italic>IKK</italic>&#x003b1; expression (<xref ref-type="bibr" rid="b42">Liu <italic>et al</italic>, 2006</xref>). However, it seems that downregulation of IKK&#x003b1; due to epigenetic silencing of the <italic>IKK</italic>&#x003b1; locus is a more common occurrence seen in close to 30&#x00025; of invasive oral SCCs (<xref ref-type="bibr" rid="b44">Maeda <italic>et al</italic>, 2007</xref>). It was also reported that overexpression of IKK&#x003b1; in the suprabasal compartment, which results in increased epidermal differentiation and reduced keratinocyte proliferation, inhibits chemically induced SCC formation and progression in mice (<xref ref-type="bibr" rid="b42">Liu <italic>et al</italic>, 2006</xref>). These results, together with enhanced SCC incidence in <italic>Ikk</italic>&#x003b1;<sup>&#x0002b;/&#x02013;</sup> mice subjected to two-stage skin carcinogenesis and loss of <italic>Ikk</italic>&#x003b1; heterozygosity in the tumours, provide evidence that IKK&#x003b1; is a tumour suppressor in the epidermis (<xref ref-type="bibr" rid="b42">Liu <italic>et al</italic>, 2006</xref>; <xref ref-type="bibr" rid="b55">Park <italic>et al</italic>, 2007</xref>). This function of IKK&#x003b1; is probably mediated through the control of keratinocyte proliferation. The loss of nuclear IKK&#x003b1; contributes to malignant conversion of keratinocytes into less differentiated and proliferative carcinoma cells. However, a recent study has suggested that increased IKK&#x003b1; may be found in acantholytic SCC (ASCC) (<xref ref-type="bibr" rid="b49">Moreno-Maldonado <italic>et al</italic>, 2008</xref>), an histologic variant of SCC showing positive staining for CKs (<xref ref-type="bibr" rid="b59">Rinker <italic>et al</italic>, 2001</xref>). Unfortunately, the authors of that study have not carefully analysed whether ASCCs present with loss of nuclear IKK&#x003b1;, which would make their results more consistent with other studies mentioned above.</p><p>SCC and other carcinoma cells are known to overproduce TGF&#x003b2;1 to modify their microenvironment through local immunosupression, extracellular matrix remodelling and neoangiogenesis, and these changes are required for tumour progression and invasiveness (<xref ref-type="bibr" rid="b53">Oft <italic>et al</italic>, 1996</xref>, <xref ref-type="bibr" rid="b52">1998</xref>; <xref ref-type="bibr" rid="b67">Siegel and Massague, 2003</xref>; <xref ref-type="bibr" rid="b37">Li <italic>et al</italic>, 2005a</xref>, <xref ref-type="bibr" rid="b36">2006</xref>). At the same time, carcinoma cells become resistant to TGF&#x003b2;-induced growth arrest (<xref ref-type="bibr" rid="b67">Siegel and Massague, 2003</xref>; <xref ref-type="bibr" rid="b37">Li <italic>et al</italic>, 2005a</xref>, <xref ref-type="bibr" rid="b36">2006</xref>). Altered IKK&#x003b1; function may contribute, at least in part, to acquired resistance to TGF&#x003b2;1-induced growth arrest.</p></sec><sec disp-level="1"><title>Conclusions and future directions</title><p>Although IKK&#x003b1; was first identified as a catalytic subunit of the IKK complex, which mediates NF-&#x003ba;B activation (<xref ref-type="bibr" rid="b9">DiDonato <italic>et al</italic>, 1997</xref>; <xref ref-type="bibr" rid="b47">Mercurio <italic>et al</italic>, 1997</xref>; <xref ref-type="bibr" rid="b57">Regnier <italic>et al</italic>, 1997</xref>; <xref ref-type="bibr" rid="b86">Zandi <italic>et al</italic>, 1997</xref>), it has quickly emerged as a multifunctional protein with several unexpected and surprising activities. In the epidermis, IKK&#x003b1; has turned out to be a critical regulator of keratinocyte proliferation, differentiation and oncogenic transformation, and this function is completely unrelated to its protein kinase activity or NF-&#x003ba;B signalling. Instead, IKK&#x003b1; functions as a cofactor for Smad2/3 in a Smad4-independent pathway that inhibits keratinocytes proliferation (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>) (<xref ref-type="fig" rid="f6">Figure 6</xref>). In this capacity, IKK&#x003b1; is required for the induction of a specific subset of TGF&#x003b2;-responsive genes that include the Myc antagonists <italic>Mad1</italic> and <italic>Ovol1</italic>, but is not needed for other well-known TGF&#x003b2; target genes, such as <italic>p21</italic>, <italic>p15</italic> and <italic>p27</italic>, encoding inhibitors of cyclin-dependent kinases (CDKs) (<xref ref-type="bibr" rid="b8">Descargues <italic>et al</italic>, 2008</xref>). This is reminiscent of the two different classes of antiproliferative gene responses: Myc repression and inhibition of CDKs, respectively, that are induced during TGF&#x003b2;-mediated cell cycle arrest (<xref ref-type="bibr" rid="b46">Massague <italic>et al</italic>, 2000</xref>). It is attractive to speculate that the tumour suppressive function of IKK&#x003b1; is exerted through this pathway as well.</p><p>Other proteins may be part of the TGF&#x003b2;&#x02013;Smad2/3&#x02013;IKK&#x003b1; signalling pathway, as revealed by two mouse models with functional alterations of 14-3-3&#x003c3; (repeated epilation mutant mice) and IRF6, the disruption of which faithfully mimics the phenotype of <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> mice (<xref ref-type="bibr" rid="b26">Herron <italic>et al</italic>, 2005</xref>; <xref ref-type="bibr" rid="b38">Li <italic>et al</italic>, 2005b</xref>; <xref ref-type="bibr" rid="b30">Ingraham <italic>et al</italic>, 2006</xref>; <xref ref-type="bibr" rid="b58">Richardson <italic>et al</italic>, 2006</xref>). 14-3-3&#x003c3; belongs to a family of adaptors that can interact with target proteins in a sequence-specific manner, although its exact function is poorly understood (<xref ref-type="bibr" rid="b48">Mhawech, 2005</xref>). It was reported that IKK&#x003b1; may protect the <italic>14-3-3</italic>&#x003c3; locus from hypermethylation in keratinocytes by interacting with histone H3 (<xref ref-type="bibr" rid="b88">Zhu <italic>et al</italic>, 2007</xref>). In that study, the authors showed that <italic>14-3-3&#x003c3;</italic> is downregulated in <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> keratinocytes, suggesting that this gene is a downstream target of IKK&#x003b1; (<xref ref-type="bibr" rid="b88">Zhu <italic>et al</italic>, 2007</xref>). The human <italic>IRF6</italic> locus is defective in Van der Woude (VWS, OMIM: 119300) and popliteal pterygium (PPS, OMIM: 11500) syndromes, which are characterized by orofacial defects such as cleft lip and palate (<xref ref-type="bibr" rid="b32">Kondo <italic>et al</italic>, 2002</xref>). IRF6 belongs to a family of transcription factors that share a highly conserved helix-turn-helix DNA-binding domain and a less conserved protein-binding domain. Interestingly, this protein-binding domain is related to the C-terminal MH2 domain of Smad proteins and has been referred to SMIR (Smad and IRF) domain (<xref ref-type="bibr" rid="b12">Eroshkin and Mushegian, 1999</xref>). As DNA binding by Smad transcription factors depends on their association with other DNA-bound transcription factors (<xref ref-type="bibr" rid="b7">Derynck and Zhang, 2003</xref>; <xref ref-type="bibr" rid="b73">ten Dijke and Hill, 2004</xref>), one can speculate that IRF6 may be a component of the Smad2/3&#x02013;IKK&#x003b1; transcriptional complex that accumulates in the keratinocyte nucleus to induce the obligatory cell cycle exit that precedes terminal differentiation (<xref ref-type="fig" rid="f6">Figure 6</xref>). In addition, IKK&#x003b1; may also interact with other transcription factors, such as RARs to control epidermal barrier formation (<xref ref-type="bibr" rid="b17">Gareus <italic>et al</italic>, 2007</xref>). The identification of other IKK&#x003b1;-interacting proteins and additional IKK&#x003b1; target genes will provide an ever better understanding of how this critical regulator of epidermal proliferation and differentiation carries out its daily work.</p></sec></body><back><ack><p>This study was supported by The International Human Frontier Science Program Organization (to PD), National Institutes of Health grants (to MK) and an American Cancer Society Research Professorship (to MK).</p></ack><ref-list><ref id="b1"><citation citation-type="journal"><name><surname>Ayer</surname><given-names>DE</given-names></name>, <name><surname>Kretzner</surname><given-names>L</given-names></name>, <name><surname>Eisenman</surname><given-names>RN</given-names></name> (<year>1993</year>) <article-title>Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity</article-title>. <source>Cell</source><volume>72</volume>: <fpage>211</fpage>&#x02013;<lpage>222</lpage><pub-id pub-id-type="pmid">8425218</pub-id></citation></ref><ref id="b2"><citation citation-type="journal"><name><surname>Candi</surname><given-names>E</given-names></name>, <name><surname>Dinsdale</surname><given-names>D</given-names></name>, <name><surname>Rufini</surname><given-names>A</given-names></name>, <name><surname>Salomoni</surname><given-names>P</given-names></name>, <name><surname>Knight</surname><given-names>RA</given-names></name>, <name><surname>Mueller</surname><given-names>M</given-names></name>, <name><surname>Krammer</surname><given-names>PH</given-names></name>, <name><surname>Melino</surname><given-names>G</given-names></name> (<year>2007</year>) <article-title>TAp63 and DeltaNp63 in cancer and epidermal development</article-title>. <source>Cell Cycle</source><volume>6</volume>: <fpage>274</fpage>&#x02013;<lpage>285</lpage><pub-id pub-id-type="pmid">17264681</pub-id></citation></ref><ref id="b3"><citation citation-type="journal"><name><surname>Candi</surname><given-names>E</given-names></name>, <name><surname>Schmidt</surname><given-names>R</given-names></name>, <name><surname>Melino</surname><given-names>G</given-names></name> (<year>2005</year>) <article-title>The cornified envelope: a model of cell death in the skin</article-title>. <source>Nat Rev Mol Cell Biol</source><volume>6</volume>: <fpage>328</fpage>&#x02013;<lpage>340</lpage><pub-id pub-id-type="pmid">15803139</pub-id></citation></ref><ref id="b4"><citation citation-type="journal"><name><surname>Chen</surname><given-names>CR</given-names></name>, <name><surname>Kang</surname><given-names>Y</given-names></name>, <name><surname>Siegel</surname><given-names>PM</given-names></name>, <name><surname>Massague</surname><given-names>J</given-names></name> (<year>2002</year>) <article-title>E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to <italic>c-myc</italic> repression</article-title>. <source>Cell</source><volume>110</volume>: <fpage>19</fpage>&#x02013;<lpage>32</lpage><pub-id pub-id-type="pmid">12150994</pub-id></citation></ref><ref id="b5"><citation citation-type="journal"><name><surname>Dai</surname><given-names>X</given-names></name>, <name><surname>Schonbaum</surname><given-names>C</given-names></name>, <name><surname>Degenstein</surname><given-names>L</given-names></name>, <name><surname>Bai</surname><given-names>W</given-names></name>, <name><surname>Mahowald</surname><given-names>A</given-names></name>, <name><surname>Fuchs</surname><given-names>E</given-names></name> (<year>1998</year>) <article-title>The ovo gene required for cuticle formation and oogenesis in flies is involved in hair formation and spermatogenesis in mice</article-title>. <source>Genes Dev</source><volume>12</volume>: <fpage>3452</fpage>&#x02013;<lpage>3463</lpage><pub-id pub-id-type="pmid">9808631</pub-id></citation></ref><ref id="b6"><citation citation-type="journal"><name><surname>Datto</surname><given-names>MB</given-names></name>, <name><surname>Frederick</surname><given-names>JP</given-names></name>, <name><surname>Pan</surname><given-names>L</given-names></name>, <name><surname>Borton</surname><given-names>AJ</given-names></name>, <name><surname>Zhuang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>XF</given-names></name> (<year>1999</year>) <article-title>Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction</article-title>. <source>Mol Cell Biol</source><volume>19</volume>: <fpage>2495</fpage>&#x02013;<lpage>2504</lpage><pub-id pub-id-type="pmid">10082515</pub-id></citation></ref><ref id="b7"><citation citation-type="journal"><name><surname>Derynck</surname><given-names>R</given-names></name>, <name><surname>Zhang</surname><given-names>YE</given-names></name> (<year>2003</year>) <article-title>Smad-dependent and Smad-independent pathways in TGF-beta family signalling</article-title>. <source>Nature</source><volume>425</volume>: <fpage>577</fpage>&#x02013;<lpage>584</lpage><pub-id pub-id-type="pmid">14534577</pub-id></citation></ref><ref id="b8"><citation citation-type="journal"><name><surname>Descargues</surname><given-names>P</given-names></name>, <name><surname>Sil</surname><given-names>AK</given-names></name>, <name><surname>Sano</surname><given-names>Y</given-names></name>, <name><surname>Korchynskyi</surname><given-names>O</given-names></name>, <name><surname>Han</surname><given-names>G</given-names></name>, <name><surname>Owens</surname><given-names>P</given-names></name>, <name><surname>Wang</surname><given-names>XJ</given-names></name>, <name><surname>Karin</surname><given-names>M</given-names></name> (<year>2008</year>) <article-title>IKKalpha is a critical coregulator of a Smad4-independent TGFbeta&#x02013;Smad2/3 signaling pathway that controls keratinocyte differentiation</article-title>. <source>Proc Natl Acad Sci USA</source><volume>105</volume>: <fpage>2487</fpage>&#x02013;<lpage>2492</lpage><pub-id pub-id-type="pmid">18268325</pub-id></citation></ref><ref id="b9"><citation citation-type="journal"><name><surname>DiDonato</surname><given-names>JA</given-names></name>, <name><surname>Hayakawa</surname><given-names>M</given-names></name>, <name><surname>Rothwarf</surname><given-names>DM</given-names></name>, <name><surname>Zandi</surname><given-names>E</given-names></name>, <name><surname>Karin</surname><given-names>M</given-names></name> (<year>1997</year>) <article-title>A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB</article-title>. <source>Nature</source><volume>388</volume>: <fpage>548</fpage>&#x02013;<lpage>554</lpage><pub-id pub-id-type="pmid">9252186</pub-id></citation></ref><ref id="b10"><citation citation-type="journal"><name><surname>Dupont</surname><given-names>S</given-names></name>, <name><surname>Zacchigna</surname><given-names>L</given-names></name>, <name><surname>Cordenonsi</surname><given-names>M</given-names></name>, <name><surname>Soligo</surname><given-names>S</given-names></name>, <name><surname>Adorno</surname><given-names>M</given-names></name>, <name><surname>Rugge</surname><given-names>M</given-names></name>, <name><surname>Piccolo</surname><given-names>S</given-names></name> (<year>2005</year>) <article-title>Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase</article-title>. <source>Cell</source><volume>121</volume>: <fpage>87</fpage>&#x02013;<lpage>99</lpage><pub-id pub-id-type="pmid">15820681</pub-id></citation></ref><ref id="b11"><citation citation-type="journal"><name><surname>Elias</surname><given-names>PM</given-names></name> (<year>2004</year>) <article-title>The epidermal permeability barrier: from the early days at Harvard to emerging concepts</article-title>. <source>J Invest Dermatol</source><volume>122</volume>: <fpage>xxxvi</fpage>&#x02013;<lpage>xxxix</lpage><pub-id pub-id-type="pmid">15009762</pub-id></citation></ref><ref id="b12"><citation citation-type="journal"><name><surname>Eroshkin</surname><given-names>A</given-names></name>, <name><surname>Mushegian</surname><given-names>A</given-names></name> (<year>1999</year>) <article-title>Conserved transactivation domain shared by interferon regulatory factors and Smad morphogens</article-title>. <source>J Mol Med</source><volume>77</volume>: <fpage>403</fpage>&#x02013;<lpage>405</lpage><pub-id pub-id-type="pmid">10426188</pub-id></citation></ref><ref id="b13"><citation citation-type="journal"><name><surname>Feng</surname><given-names>XH</given-names></name>, <name><surname>Derynck</surname><given-names>R</given-names></name> (<year>2005</year>) <article-title>Specificity and versatility in tgf-beta signaling through Smads</article-title>. <source>Annu Rev Cell Dev Biol</source><volume>21</volume>: <fpage>659</fpage>&#x02013;<lpage>693</lpage><pub-id pub-id-type="pmid">16212511</pub-id></citation></ref><ref id="b14"><citation citation-type="journal"><name><surname>Foley</surname><given-names>KP</given-names></name>, <name><surname>McArthur</surname><given-names>GA</given-names></name>, <name><surname>Queva</surname><given-names>C</given-names></name>, <name><surname>Hurlin</surname><given-names>PJ</given-names></name>, <name><surname>Soriano</surname><given-names>P</given-names></name>, <name><surname>Eisenman</surname><given-names>RN</given-names></name> (<year>1998</year>) <article-title>Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation</article-title>. <source>EMBO J</source><volume>17</volume>: <fpage>774</fpage>&#x02013;<lpage>785</lpage><pub-id pub-id-type="pmid">9451002</pub-id></citation></ref><ref id="b15"><citation citation-type="journal"><name><surname>Fuchs</surname><given-names>E</given-names></name>, <name><surname>Byrne</surname><given-names>C</given-names></name> (<year>1994</year>) <article-title>The epidermis: rising to the surface</article-title>. <source>Curr Opin Genet Dev</source><volume>4</volume>: <fpage>725</fpage>&#x02013;<lpage>736</lpage><pub-id pub-id-type="pmid">7531523</pub-id></citation></ref><ref id="b16"><citation citation-type="journal"><name><surname>Fuchs</surname><given-names>E</given-names></name>, <name><surname>Green</surname><given-names>H</given-names></name> (<year>1980</year>) <article-title>Changes in keratin gene expression during terminal differentiation of the keratinocyte</article-title>. <source>Cell</source><volume>19</volume>: <fpage>1033</fpage>&#x02013;<lpage>1042</lpage><pub-id pub-id-type="pmid">6155214</pub-id></citation></ref><ref id="b17"><citation citation-type="journal"><name><surname>Gareus</surname><given-names>R</given-names></name>, <name><surname>Huth</surname><given-names>M</given-names></name>, <name><surname>Breiden</surname><given-names>B</given-names></name>, <name><surname>Nenci</surname><given-names>A</given-names></name>, <name><surname>Rosch</surname><given-names>N</given-names></name>, <name><surname>Haase</surname><given-names>I</given-names></name>, <name><surname>Bloch</surname><given-names>W</given-names></name>, <name><surname>Sandhoff</surname><given-names>K</given-names></name>, <name><surname>Pasparakis</surname><given-names>M</given-names></name> (<year>2007</year>) <article-title>Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation</article-title>. <source>Nat Cell Biol</source><volume>9</volume>: <fpage>461</fpage>&#x02013;<lpage>469</lpage><pub-id pub-id-type="pmid">17351639</pub-id></citation></ref><ref id="b18"><citation citation-type="journal"><name><surname>Gomis</surname><given-names>RR</given-names></name>, <name><surname>Alarcon</surname><given-names>C</given-names></name>, <name><surname>He</surname><given-names>W</given-names></name>, <name><surname>Wang</surname><given-names>Q</given-names></name>, <name><surname>Seoane</surname><given-names>J</given-names></name>, <name><surname>Lash</surname><given-names>A</given-names></name>, <name><surname>Massague</surname><given-names>J</given-names></name> (<year>2006</year>) <article-title>A FoxO-Smad synexpression group in human keratinocytes</article-title>. <source>Proc Natl Acad Sci USA</source><volume>103</volume>: <fpage>12747</fpage>&#x02013;<lpage>12752</lpage><pub-id pub-id-type="pmid">16908841</pub-id></citation></ref><ref id="b19"><citation citation-type="journal"><name><surname>Grandori</surname><given-names>C</given-names></name>, <name><surname>Cowley</surname><given-names>SM</given-names></name>, <name><surname>James</surname><given-names>LP</given-names></name>, <name><surname>Eisenman</surname><given-names>RN</given-names></name> (<year>2000</year>) <article-title>The Myc/Max/Mad network and the transcriptional control of cell behavior</article-title>. <source>Annu Rev Cell Dev Biol</source><volume>16</volume>: <fpage>653</fpage>&#x02013;<lpage>699</lpage><pub-id pub-id-type="pmid">11031250</pub-id></citation></ref><ref id="b20"><citation citation-type="journal"><name><surname>Gugasyan</surname><given-names>R</given-names></name>, <name><surname>Voss</surname><given-names>A</given-names></name>, <name><surname>Varigos</surname><given-names>G</given-names></name>, <name><surname>Thomas</surname><given-names>T</given-names></name>, <name><surname>Grumont</surname><given-names>RJ</given-names></name>, <name><surname>Kaur</surname><given-names>P</given-names></name>, <name><surname>Grigoriadis</surname><given-names>G</given-names></name>, <name><surname>Gerondakis</surname><given-names>S</given-names></name> (<year>2004</year>) <article-title>The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms</article-title>. <source>Mol Cell Biol</source><volume>24</volume>: <fpage>5733</fpage>&#x02013;<lpage>5745</lpage><pub-id pub-id-type="pmid">15199130</pub-id></citation></ref><ref id="b21"><citation citation-type="journal"><name><surname>Hampton</surname><given-names>T</given-names></name> (<year>2005</year>) <article-title>Skin cancer's ranks rise: immunosuppression to blame</article-title>. <source>JAMA</source><volume>294</volume>: <fpage>1476</fpage>&#x02013;<lpage>1480</lpage><pub-id pub-id-type="pmid">16189357</pub-id></citation></ref><ref id="b22"><citation citation-type="journal"><name><surname>Hardisson</surname><given-names>D</given-names></name> (<year>2003</year>) <article-title>Molecular pathogenesis of head and neck squamous cell carcinoma</article-title>. <source>Eur Arch Otorhinolaryngol</source><volume>260</volume>: <fpage>502</fpage>&#x02013;<lpage>508</lpage><pub-id pub-id-type="pmid">12736744</pub-id></citation></ref><ref id="b23"><citation citation-type="journal"><name><surname>Hardman</surname><given-names>MJ</given-names></name>, <name><surname>Sisi</surname><given-names>P</given-names></name>, <name><surname>Banbury</surname><given-names>DN</given-names></name>, <name><surname>Byrne</surname><given-names>C</given-names></name> (<year>1998</year>) <article-title>Patterned acquisition of skin barrier function during development</article-title>. <source>Development</source><volume>125</volume>: <fpage>1541</fpage>&#x02013;<lpage>1552</lpage><pub-id pub-id-type="pmid">9502735</pub-id></citation></ref><ref id="b24"><citation citation-type="journal"><name><surname>He</surname><given-names>W</given-names></name>, <name><surname>Cao</surname><given-names>T</given-names></name>, <name><surname>Smith</surname><given-names>DA</given-names></name>, <name><surname>Myers</surname><given-names>TE</given-names></name>, <name><surname>Wang</surname><given-names>XJ</given-names></name> (<year>2001</year>) <article-title>Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis</article-title>. <source>Oncogene</source><volume>20</volume>: <fpage>471</fpage>&#x02013;<lpage>483</lpage><pub-id pub-id-type="pmid">11313978</pub-id></citation></ref><ref id="b25"><citation citation-type="journal"><name><surname>He</surname><given-names>W</given-names></name>, <name><surname>Dorn</surname><given-names>DC</given-names></name>, <name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name>, <name><surname>Tempst</surname><given-names>P</given-names></name>, <name><surname>Moore</surname><given-names>MA</given-names></name>, <name><surname>Massague</surname><given-names>J</given-names></name> (<year>2006</year>) <article-title>Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway</article-title>. <source>Cell</source><volume>125</volume>: <fpage>929</fpage>&#x02013;<lpage>941</lpage><pub-id pub-id-type="pmid">16751102</pub-id></citation></ref><ref id="b26"><citation citation-type="journal"><name><surname>Herron</surname><given-names>BJ</given-names></name>, <name><surname>Liddell</surname><given-names>RA</given-names></name>, <name><surname>Parker</surname><given-names>A</given-names></name>, <name><surname>Grant</surname><given-names>S</given-names></name>, <name><surname>Kinne</surname><given-names>J</given-names></name>, <name><surname>Fisher</surname><given-names>JK</given-names></name>, <name><surname>Siracusa</surname><given-names>LD</given-names></name> (<year>2005</year>) <article-title>A mutation in stratifin is responsible for the repeated epilation (Er) phenotype in mice</article-title>. <source>Nat Genet</source><volume>37</volume>: <fpage>1210</fpage>&#x02013;<lpage>1212</lpage><pub-id pub-id-type="pmid">16200063</pub-id></citation></ref><ref id="b27"><citation citation-type="journal"><name><surname>Heyer</surname><given-names>J</given-names></name>, <name><surname>Escalante-Alcalde</surname><given-names>D</given-names></name>, <name><surname>Lia</surname><given-names>M</given-names></name>, <name><surname>Boettinger</surname><given-names>E</given-names></name>, <name><surname>Edelmann</surname><given-names>W</given-names></name>, <name><surname>Stewart</surname><given-names>CL</given-names></name>, <name><surname>Kucherlapati</surname><given-names>R</given-names></name> (<year>1999</year>) <article-title>Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis</article-title>. <source>Proc Natl Acad Sci USA</source><volume>96</volume>: <fpage>12595</fpage>&#x02013;<lpage>12600</lpage><pub-id pub-id-type="pmid">10535967</pub-id></citation></ref><ref id="b28"><citation citation-type="journal"><name><surname>Hu</surname><given-names>Y</given-names></name>, <name><surname>Baud</surname><given-names>V</given-names></name>, <name><surname>Delhase</surname><given-names>M</given-names></name>, <name><surname>Zhang</surname><given-names>P</given-names></name>, <name><surname>Deerinck</surname><given-names>T</given-names></name>, <name><surname>Ellisman</surname><given-names>M</given-names></name>, <name><surname>Johnson</surname><given-names>R</given-names></name>, <name><surname>Karin</surname><given-names>M</given-names></name> (<year>1999</year>) <article-title>Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase</article-title>. <source>Science</source><volume>284</volume>: <fpage>316</fpage>&#x02013;<lpage>320</lpage><pub-id pub-id-type="pmid">10195896</pub-id></citation></ref><ref id="b29"><citation citation-type="journal"><name><surname>Hu</surname><given-names>Y</given-names></name>, <name><surname>Baud</surname><given-names>V</given-names></name>, <name><surname>Oga</surname><given-names>T</given-names></name>, <name><surname>Kim</surname><given-names>KI</given-names></name>, <name><surname>Yoshida</surname><given-names>K</given-names></name>, <name><surname>Karin</surname><given-names>M</given-names></name> (<year>2001</year>) <article-title>IKKalpha controls formation of the epidermis independently of NF-kappaB</article-title>. <source>Nature</source><volume>410</volume>: <fpage>710</fpage>&#x02013;<lpage>714</lpage><pub-id pub-id-type="pmid">11287960</pub-id></citation></ref><ref id="b30"><citation citation-type="journal"><name><surname>Ingraham</surname><given-names>CR</given-names></name>, <name><surname>Kinoshita</surname><given-names>A</given-names></name>, <name><surname>Kondo</surname><given-names>S</given-names></name>, <name><surname>Yang</surname><given-names>B</given-names></name>, <name><surname>Sajan</surname><given-names>S</given-names></name>, <name><surname>Trout</surname><given-names>KJ</given-names></name>, <name><surname>Malik</surname><given-names>MI</given-names></name>, <name><surname>Dunnwald</surname><given-names>M</given-names></name>, <name><surname>Goudy</surname><given-names>SL</given-names></name>, <name><surname>Lovett</surname><given-names>M</given-names></name>, <name><surname>Murray</surname><given-names>JC</given-names></name>, <name><surname>Schutte</surname><given-names>BC</given-names></name> (<year>2006</year>) <article-title>Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6)</article-title>. <source>Nat Genet</source><volume>38</volume>: <fpage>1335</fpage>&#x02013;<lpage>1340</lpage><pub-id pub-id-type="pmid">17041601</pub-id></citation></ref><ref id="b31"><citation citation-type="journal"><name><surname>Johnson</surname><given-names>TM</given-names></name>, <name><surname>Rowe</surname><given-names>DE</given-names></name>, <name><surname>Nelson</surname><given-names>BR</given-names></name>, <name><surname>Swanson</surname><given-names>NA</given-names></name> (<year>1992</year>) <article-title>Squamous cell carcinoma of the skin (excluding lip and oral mucosa)</article-title>. <source>J Am Acad Dermatol</source><volume>26</volume><issue>(3 Part 2)</issue>: <fpage>467</fpage>&#x02013;<lpage>484</lpage><pub-id pub-id-type="pmid">1564155</pub-id></citation></ref><ref id="b32"><citation citation-type="journal"><name><surname>Kondo</surname><given-names>S</given-names></name>, <name><surname>Schutte</surname><given-names>BC</given-names></name>, <name><surname>Richardson</surname><given-names>RJ</given-names></name>, <name><surname>Bjork</surname><given-names>BC</given-names></name>, <name><surname>Knight</surname><given-names>AS</given-names></name>, <name><surname>Watanabe</surname><given-names>Y</given-names></name>, <name><surname>Howard</surname><given-names>E</given-names></name>, <name><surname>de Lima</surname><given-names>RL</given-names></name>, <name><surname>Daack-Hirsch</surname><given-names>S</given-names></name>, <name><surname>Sander</surname><given-names>A</given-names></name>, <name><surname>McDonald-McGinn</surname><given-names>DM</given-names></name>, <name><surname>Zackai</surname><given-names>EH</given-names></name>, <name><surname>Lammer</surname><given-names>EJ</given-names></name>, <name><surname>Aylsworth</surname><given-names>AS</given-names></name>, <name><surname>Ardinger</surname><given-names>HH</given-names></name>, <name><surname>Lidral</surname><given-names>AC</given-names></name>, <name><surname>Pober</surname><given-names>BR</given-names></name>, <name><surname>Moreno</surname><given-names>L</given-names></name>, <name><surname>Arcos-Burgos</surname><given-names>M</given-names></name>, <name><surname>Valencia</surname><given-names>C</given-names></name><etal/> (<year>2002</year>) <article-title>Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes</article-title>. <source>Nat Genet</source><volume>32</volume>: <fpage>285</fpage>&#x02013;<lpage>289</lpage><pub-id pub-id-type="pmid">12219090</pub-id></citation></ref><ref id="b33"><citation citation-type="journal"><name><surname>Koster</surname><given-names>MI</given-names></name>, <name><surname>Dai</surname><given-names>D</given-names></name>, <name><surname>Marinari</surname><given-names>B</given-names></name>, <name><surname>Sano</surname><given-names>Y</given-names></name>, <name><surname>Costanzo</surname><given-names>A</given-names></name>, <name><surname>Karin</surname><given-names>M</given-names></name>, <name><surname>Roop</surname><given-names>DR</given-names></name> (<year>2007</year>) <article-title>p63 induces key target genes required for epidermal morphogenesis</article-title>. <source>Proc Natl Acad Sci USA</source><volume>104</volume>: <fpage>3255</fpage>&#x02013;<lpage>3260</lpage><pub-id pub-id-type="pmid">17360634</pub-id></citation></ref><ref id="b34"><citation citation-type="journal"><name><surname>Koster</surname><given-names>MI</given-names></name>, <name><surname>Roop</surname><given-names>DR</given-names></name> (<year>2007</year>) <article-title>Mechanisms regulating epithelial stratification</article-title>. <source>Annu Rev Cell Dev Biol</source><volume>23</volume>: <fpage>93</fpage>&#x02013;<lpage>113</lpage><pub-id pub-id-type="pmid">17489688</pub-id></citation></ref><ref id="b35"><citation citation-type="journal"><name><surname>Li</surname><given-names>AG</given-names></name>, <name><surname>Koster</surname><given-names>MI</given-names></name>, <name><surname>Wang</surname><given-names>XJ</given-names></name> (<year>2003</year>) <article-title>Roles of TGFbeta signaling in epidermal/appendage development</article-title>. <source>Cytokine Growth Factor Rev</source><volume>14</volume>: <fpage>99</fpage>&#x02013;<lpage>111</lpage><pub-id pub-id-type="pmid">12651222</pub-id></citation></ref><ref id="b36"><citation citation-type="journal"><name><surname>Li</surname><given-names>AG</given-names></name>, <name><surname>Lu</surname><given-names>SL</given-names></name>, <name><surname>Han</surname><given-names>G</given-names></name>, <name><surname>Hoot</surname><given-names>KE</given-names></name>, <name><surname>Wang</surname><given-names>XJ</given-names></name> (<year>2006</year>) <article-title>Role of TGFbeta in skin inflammation and carcinogenesis</article-title>. <source>Mol Carcinog</source><volume>45</volume>: <fpage>389</fpage>&#x02013;<lpage>396</lpage><pub-id pub-id-type="pmid">16673381</pub-id></citation></ref><ref id="b37"><citation citation-type="journal"><name><surname>Li</surname><given-names>AG</given-names></name>, <name><surname>Lu</surname><given-names>SL</given-names></name>, <name><surname>Han</surname><given-names>G</given-names></name>, <name><surname>Kulesz-Martin</surname><given-names>M</given-names></name>, <name><surname>Wang</surname><given-names>XJ</given-names></name> (<year>2005a</year>) <article-title>Current view of the role of transforming growth factor beta 1 in skin carcinogenesis</article-title>. <source>J Investig Dermatol Symp Proc</source><volume>10</volume>: <fpage>110</fpage>&#x02013;<lpage>117</lpage></citation></ref><ref id="b38"><citation citation-type="journal"><name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Lu</surname><given-names>Q</given-names></name>, <name><surname>Estepa</surname><given-names>G</given-names></name>, <name><surname>Verma</surname><given-names>IM</given-names></name> (<year>2005b</year>) <article-title>Identification of 14-3-3sigma mutation causing cutaneous abnormality in repeated-epilation mutant mouse</article-title>. <source>Proc Natl Acad Sci USA</source><volume>102</volume>: <fpage>15977</fpage>&#x02013;<lpage>15982</lpage><pub-id pub-id-type="pmid">16239341</pub-id></citation></ref><ref id="b39"><citation citation-type="journal"><name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Lu</surname><given-names>Q</given-names></name>, <name><surname>Hwang</surname><given-names>JY</given-names></name>, <name><surname>Buscher</surname><given-names>D</given-names></name>, <name><surname>Lee</surname><given-names>KF</given-names></name>, <name><surname>Izpisua-Belmonte</surname><given-names>JC</given-names></name>, <name><surname>Verma</surname><given-names>IM</given-names></name> (<year>1999a</year>) <article-title>IKK1-deficient mice exhibit abnormal development of skin and skeleton</article-title>. <source>Genes Dev</source><volume>13</volume>: <fpage>1322</fpage>&#x02013;<lpage>1328</lpage><pub-id pub-id-type="pmid">10346820</pub-id></citation></ref><ref id="b40"><citation citation-type="journal"><name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Van Antwerp</surname><given-names>D</given-names></name>, <name><surname>Mercurio</surname><given-names>F</given-names></name>, <name><surname>Lee</surname><given-names>KF</given-names></name>, <name><surname>Verma</surname><given-names>IM</given-names></name> (<year>1999b</year>) <article-title>Severe liver degeneration in mice lacking the IkappaB kinase 2 gene</article-title>. <source>Science</source><volume>284</volume>: <fpage>321</fpage>&#x02013;<lpage>325</lpage><pub-id pub-id-type="pmid">10195897</pub-id></citation></ref><ref id="b41"><citation citation-type="journal"><name><surname>Li</surname><given-names>ZW</given-names></name>, <name><surname>Chu</surname><given-names>W</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <name><surname>Delhase</surname><given-names>M</given-names></name>, <name><surname>Deerinck</surname><given-names>T</given-names></name>, <name><surname>Ellisman</surname><given-names>M</given-names></name>, <name><surname>Johnson</surname><given-names>R</given-names></name>, <name><surname>Karin</surname><given-names>M</given-names></name> (<year>1999c</year>) <article-title>The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis</article-title>. <source>J Exp Med</source><volume>189</volume>: <fpage>1839</fpage>&#x02013;<lpage>1845</lpage><pub-id pub-id-type="pmid">10359587</pub-id></citation></ref><ref id="b42"><citation citation-type="journal"><name><surname>Liu</surname><given-names>B</given-names></name>, <name><surname>Park</surname><given-names>E</given-names></name>, <name><surname>Zhu</surname><given-names>F</given-names></name>, <name><surname>Bustos</surname><given-names>T</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Shen</surname><given-names>J</given-names></name>, <name><surname>Fischer</surname><given-names>SM</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name> (<year>2006</year>) <article-title>A critical role for I kappaB kinase alpha in the development of human and mouse squamous cell carcinomas</article-title>. <source>Proc Natl Acad Sci USA</source><volume>103</volume>: <fpage>17202</fpage>&#x02013;<lpage>17207</lpage><pub-id pub-id-type="pmid">17079494</pub-id></citation></ref><ref id="b43"><citation citation-type="journal"><name><surname>M'Boneko</surname><given-names>V</given-names></name>, <name><surname>Merker</surname><given-names>HJ</given-names></name> (<year>1988</year>) <article-title>Development and morphology of the periderm of mouse embryos (days 9&#x02013;12 of gestation)</article-title>. <source>Acta Anat (Basel)</source><volume>133</volume>: <fpage>325</fpage>&#x02013;<lpage>336</lpage><pub-id pub-id-type="pmid">3227794</pub-id></citation></ref><ref id="b44"><citation citation-type="journal"><name><surname>Maeda</surname><given-names>G</given-names></name>, <name><surname>Chiba</surname><given-names>T</given-names></name>, <name><surname>Kawashiri</surname><given-names>S</given-names></name>, <name><surname>Satoh</surname><given-names>T</given-names></name>, <name><surname>Imai</surname><given-names>K</given-names></name> (<year>2007</year>) <article-title>Epigenetic inactivation of IkappaB Kinase-alpha in oral carcinomas and tumor progression</article-title>. <source>Clin Cancer Res</source><volume>13</volume>: <fpage>5041</fpage>&#x02013;<lpage>5047</lpage><pub-id pub-id-type="pmid">17785555</pub-id></citation></ref><ref id="b45"><citation citation-type="journal"><name><surname>Massague</surname><given-names>J</given-names></name> (<year>2000</year>) <article-title>How cells read TGF-beta signals</article-title>. <source>Nat Rev Mol Cell Biol</source><volume>1</volume>: <fpage>169</fpage>&#x02013;<lpage>178</lpage><pub-id pub-id-type="pmid">11252892</pub-id></citation></ref><ref id="b46"><citation citation-type="journal"><name><surname>Massague</surname><given-names>J</given-names></name>, <name><surname>Blain</surname><given-names>SW</given-names></name>, <name><surname>Lo</surname><given-names>RS</given-names></name> (<year>2000</year>) <article-title>TGFbeta signaling in growth control, cancer, and heritable disorders</article-title>. <source>Cell</source><volume>103</volume>: <fpage>295</fpage>&#x02013;<lpage>309</lpage><pub-id pub-id-type="pmid">11057902</pub-id></citation></ref><ref id="b47"><citation citation-type="journal"><name><surname>Mercurio</surname><given-names>F</given-names></name>, <name><surname>Zhu</surname><given-names>H</given-names></name>, <name><surname>Murray</surname><given-names>BW</given-names></name>, <name><surname>Shevchenko</surname><given-names>A</given-names></name>, <name><surname>Bennett</surname><given-names>BL</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Young</surname><given-names>DB</given-names></name>, <name><surname>Barbosa</surname><given-names>M</given-names></name>, <name><surname>Mann</surname><given-names>M</given-names></name>, <name><surname>Manning</surname><given-names>A</given-names></name>, <name><surname>Rao</surname><given-names>A</given-names></name> (<year>1997</year>) <article-title>IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation</article-title>. <source>Science</source><volume>278</volume>: <fpage>860</fpage>&#x02013;<lpage>866</lpage><pub-id pub-id-type="pmid">9346484</pub-id></citation></ref><ref id="b48"><citation citation-type="journal"><name><surname>Mhawech</surname><given-names>P</given-names></name> (<year>2005</year>) <article-title>14-3-3 proteins&#x02014;an update</article-title>. <source>Cell Res</source><volume>15</volume>: <fpage>228</fpage>&#x02013;<lpage>236</lpage><pub-id pub-id-type="pmid">15857577</pub-id></citation></ref><ref id="b49"><citation citation-type="journal"><name><surname>Moreno-Maldonado</surname><given-names>R</given-names></name>, <name><surname>Ramirez</surname><given-names>A</given-names></name>, <name><surname>Navarro</surname><given-names>M</given-names></name>, <name><surname>Fernandez-Acenero</surname><given-names>MJ</given-names></name>, <name><surname>Villanueva</surname><given-names>C</given-names></name>, <name><surname>Page</surname><given-names>A</given-names></name>, <name><surname>Jorcano</surname><given-names>JL</given-names></name>, <name><surname>Bravo</surname><given-names>A</given-names></name>, <name><surname>Llanos Casanova</surname><given-names>M</given-names></name> (<year>2008</year>) <article-title>IKKalpha enhances human keratinocyte differentiation and determines the histological variant of epidermal squamous cell carcinomas</article-title>. <source>Cell Cycle</source><volume>7</volume>: <fpage>2021</fpage>&#x02013;<lpage>2029</lpage><pub-id pub-id-type="pmid">18604171</pub-id></citation></ref><ref id="b50"><citation citation-type="journal"><name><surname>Nair</surname><given-names>M</given-names></name>, <name><surname>Teng</surname><given-names>A</given-names></name>, <name><surname>Bilanchone</surname><given-names>V</given-names></name>, <name><surname>Agrawal</surname><given-names>A</given-names></name>, <name><surname>Li</surname><given-names>B</given-names></name>, <name><surname>Dai</surname><given-names>X</given-names></name> (<year>2006</year>) <article-title>Ovol1 regulates the growth arrest of embryonic epidermal progenitor cells and represses <italic>c-myc</italic> transcription</article-title>. <source>J Cell Biol</source><volume>173</volume>: <fpage>253</fpage>&#x02013;<lpage>264</lpage><pub-id pub-id-type="pmid">16636146</pub-id></citation></ref><ref id="b51"><citation citation-type="journal"><name><surname>Nomura</surname><given-names>M</given-names></name>, <name><surname>Li</surname><given-names>E</given-names></name> (<year>1998</year>) <article-title>Smad2 role in mesoderm formation, left-right patterning and craniofacial development</article-title>. <source>Nature</source><volume>393</volume>: <fpage>786</fpage>&#x02013;<lpage>790</lpage><pub-id pub-id-type="pmid">9655392</pub-id></citation></ref><ref id="b52"><citation citation-type="journal"><name><surname>Oft</surname><given-names>M</given-names></name>, <name><surname>Heider</surname><given-names>KH</given-names></name>, <name><surname>Beug</surname><given-names>H</given-names></name> (<year>1998</year>) <article-title>TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis</article-title>. <source>Curr Biol</source><volume>8</volume>: <fpage>1243</fpage>&#x02013;<lpage>1252</lpage><pub-id pub-id-type="pmid">9822576</pub-id></citation></ref><ref id="b53"><citation citation-type="journal"><name><surname>Oft</surname><given-names>M</given-names></name>, <name><surname>Peli</surname><given-names>J</given-names></name>, <name><surname>Rudaz</surname><given-names>C</given-names></name>, <name><surname>Schwarz</surname><given-names>H</given-names></name>, <name><surname>Beug</surname><given-names>H</given-names></name>, <name><surname>Reichmann</surname><given-names>E</given-names></name> (<year>1996</year>) <article-title>TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells</article-title>. <source>Genes Dev</source><volume>10</volume>: <fpage>2462</fpage>&#x02013;<lpage>2477</lpage><pub-id pub-id-type="pmid">8843198</pub-id></citation></ref><ref id="b54"><citation citation-type="journal"><name><surname>Owens</surname><given-names>P</given-names></name>, <name><surname>Han</surname><given-names>G</given-names></name>, <name><surname>Li</surname><given-names>AG</given-names></name>, <name><surname>Wang</surname><given-names>XJ</given-names></name> (<year>2008</year>) <article-title>The role of Smads in skin development</article-title>. <source>J Invest Dermatol</source><volume>128</volume>: <fpage>783</fpage>&#x02013;<lpage>790</lpage><pub-id pub-id-type="pmid">18337711</pub-id></citation></ref><ref id="b55"><citation citation-type="journal"><name><surname>Park</surname><given-names>E</given-names></name>, <name><surname>Zhu</surname><given-names>F</given-names></name>, <name><surname>Liu</surname><given-names>B</given-names></name>, <name><surname>Xia</surname><given-names>X</given-names></name>, <name><surname>Shen</surname><given-names>J</given-names></name>, <name><surname>Bustos</surname><given-names>T</given-names></name>, <name><surname>Fischer</surname><given-names>SM</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name> (<year>2007</year>) <article-title>Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas</article-title>. <source>Cancer Res</source><volume>67</volume>: <fpage>9158</fpage>&#x02013;<lpage>9168</lpage><pub-id pub-id-type="pmid">17909021</pub-id></citation></ref><ref id="b56"><citation citation-type="journal"><name><surname>Qiao</surname><given-names>W</given-names></name>, <name><surname>Li</surname><given-names>AG</given-names></name>, <name><surname>Owens</surname><given-names>P</given-names></name>, <name><surname>Xu</surname><given-names>X</given-names></name>, <name><surname>Wang</surname><given-names>XJ</given-names></name>, <name><surname>Deng</surname><given-names>CX</given-names></name> (<year>2006</year>) <article-title>Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin</article-title>. <source>Oncogene</source><volume>25</volume>: <fpage>207</fpage>&#x02013;<lpage>217</lpage><pub-id pub-id-type="pmid">16170355</pub-id></citation></ref><ref id="b57"><citation citation-type="journal"><name><surname>Regnier</surname><given-names>CH</given-names></name>, <name><surname>Song</surname><given-names>HY</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>, <name><surname>Goeddel</surname><given-names>DV</given-names></name>, <name><surname>Cao</surname><given-names>Z</given-names></name>, <name><surname>Rothe</surname><given-names>M</given-names></name> (<year>1997</year>) <article-title>Identification and characterization of an IkappaB kinase</article-title>. <source>Cell</source><volume>90</volume>: <fpage>373</fpage>&#x02013;<lpage>383</lpage><pub-id pub-id-type="pmid">9244310</pub-id></citation></ref><ref id="b58"><citation citation-type="journal"><name><surname>Richardson</surname><given-names>RJ</given-names></name>, <name><surname>Dixon</surname><given-names>J</given-names></name>, <name><surname>Malhotra</surname><given-names>S</given-names></name>, <name><surname>Hardman</surname><given-names>MJ</given-names></name>, <name><surname>Knowles</surname><given-names>L</given-names></name>, <name><surname>Boot-Handford</surname><given-names>RP</given-names></name>, <name><surname>Shore</surname><given-names>P</given-names></name>, <name><surname>Whitmarsh</surname><given-names>A</given-names></name>, <name><surname>Dixon</surname><given-names>MJ</given-names></name> (<year>2006</year>) <article-title>Irf6 is a key determinant of the keratinocyte proliferation&#x02013;differentiation switch</article-title>. <source>Nat Genet</source><volume>38</volume>: <fpage>1329</fpage>&#x02013;<lpage>1334</lpage><pub-id pub-id-type="pmid">17041603</pub-id></citation></ref><ref id="b59"><citation citation-type="journal"><name><surname>Rinker</surname><given-names>MH</given-names></name>, <name><surname>Fenske</surname><given-names>NA</given-names></name>, <name><surname>Scalf</surname><given-names>LA</given-names></name>, <name><surname>Glass</surname><given-names>LF</given-names></name> (<year>2001</year>) <article-title>Histologic variants of squamous cell carcinoma of the skin</article-title>. <source>Cancer Control</source><volume>8</volume>: <fpage>354</fpage>&#x02013;<lpage>363</lpage><pub-id pub-id-type="pmid">11483889</pub-id></citation></ref><ref id="b60"><citation citation-type="journal"><name><surname>Rothwarf</surname><given-names>DM</given-names></name>, <name><surname>Zandi</surname><given-names>E</given-names></name>, <name><surname>Natoli</surname><given-names>G</given-names></name>, <name><surname>Karin</surname><given-names>M</given-names></name> (<year>1998</year>) <article-title>IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex</article-title>. <source>Nature</source><volume>395</volume>: <fpage>297</fpage>&#x02013;<lpage>300</lpage><pub-id pub-id-type="pmid">9751060</pub-id></citation></ref><ref id="b61"><citation citation-type="journal"><name><surname>Rotzer</surname><given-names>D</given-names></name>, <name><surname>Krampert</surname><given-names>M</given-names></name>, <name><surname>Sulyok</surname><given-names>S</given-names></name>, <name><surname>Braun</surname><given-names>S</given-names></name>, <name><surname>Stark</surname><given-names>HJ</given-names></name>, <name><surname>Boukamp</surname><given-names>P</given-names></name>, <name><surname>Werner</surname><given-names>S</given-names></name> (<year>2006</year>) <article-title>Id proteins: novel targets of activin action, which regulate epidermal homeostasis</article-title>. <source>Oncogene</source><volume>25</volume>: <fpage>2070</fpage>&#x02013;<lpage>2081</lpage><pub-id pub-id-type="pmid">16288215</pub-id></citation></ref><ref id="b62"><citation citation-type="journal"><name><surname>Rudolph</surname><given-names>R</given-names></name>, <name><surname>Zelac</surname><given-names>DE</given-names></name> (<year>2004</year>) <article-title>Squamous cell carcinoma of the skin</article-title>. <source>Plast Reconstr Surg</source><volume>114</volume>: <fpage>82e</fpage>&#x02013;<lpage>94e</lpage></citation></ref><ref id="b63"><citation citation-type="journal"><name><surname>Schmierer</surname><given-names>B</given-names></name>, <name><surname>Hill</surname><given-names>CS</given-names></name> (<year>2007</year>) <article-title>TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility</article-title>. <source>Nat Rev Mol Cell Biol</source><volume>8</volume>: <fpage>970</fpage>&#x02013;<lpage>982</lpage><pub-id pub-id-type="pmid">18000526</pub-id></citation></ref><ref id="b64"><citation citation-type="journal"><name><surname>Segre</surname><given-names>JA</given-names></name> (<year>2006</year>) <article-title>Epidermal barrier formation and recovery in skin disorders</article-title>. <source>J Clin Invest</source><volume>116</volume>: <fpage>1150</fpage>&#x02013;<lpage>1158</lpage><pub-id pub-id-type="pmid">16670755</pub-id></citation></ref><ref id="b65"><citation citation-type="journal"><name><surname>Seitz</surname><given-names>CS</given-names></name>, <name><surname>Lin</surname><given-names>Q</given-names></name>, <name><surname>Deng</surname><given-names>H</given-names></name>, <name><surname>Khavari</surname><given-names>PA</given-names></name> (<year>1998</year>) <article-title>Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB</article-title>. <source>Proc Natl Acad Sci USA</source><volume>95</volume>: <fpage>2307</fpage>&#x02013;<lpage>2312</lpage><pub-id pub-id-type="pmid">9482881</pub-id></citation></ref><ref id="b66"><citation citation-type="journal"><name><surname>Shi</surname><given-names>Y</given-names></name>, <name><surname>Massague</surname><given-names>J</given-names></name> (<year>2003</year>) <article-title>Mechanisms of TGF-beta signaling from cell membrane to the nucleus</article-title>. <source>Cell</source><volume>113</volume>: <fpage>685</fpage>&#x02013;<lpage>700</lpage><pub-id pub-id-type="pmid">12809600</pub-id></citation></ref><ref id="b67"><citation citation-type="journal"><name><surname>Siegel</surname><given-names>PM</given-names></name>, <name><surname>Massague</surname><given-names>J</given-names></name> (<year>2003</year>) <article-title>Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer</article-title>. <source>Nat Rev Cancer</source><volume>3</volume>: <fpage>807</fpage>&#x02013;<lpage>821</lpage><pub-id pub-id-type="pmid">14557817</pub-id></citation></ref><ref id="b68"><citation citation-type="journal"><name><surname>Sil</surname><given-names>AK</given-names></name>, <name><surname>Maeda</surname><given-names>S</given-names></name>, <name><surname>Sano</surname><given-names>Y</given-names></name>, <name><surname>Roop</surname><given-names>DR</given-names></name>, <name><surname>Karin</surname><given-names>M</given-names></name> (<year>2004</year>) <article-title>IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis</article-title>. <source>Nature</source><volume>428</volume>: <fpage>660</fpage>&#x02013;<lpage>664</lpage><pub-id pub-id-type="pmid">15071597</pub-id></citation></ref><ref id="b69"><citation citation-type="journal"><name><surname>Silverman</surname><given-names>S.</given-names><suffix>Jr</suffix></name> (<year>2001</year>) <article-title>Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge</article-title>. <source>J Am Dent Assoc</source><volume>132</volume><issue>(Suppl.)</issue>: <fpage>7S</fpage>&#x02013;<lpage>11S</lpage><pub-id pub-id-type="pmid">11803655</pub-id></citation></ref><ref id="b70"><citation citation-type="journal"><name><surname>Smart</surname><given-names>IH</given-names></name> (<year>1970</year>) <article-title>Variation in the plane of cell cleavage during the process of stratification in the mouse epidermis</article-title>. <source>Br J Dermatol</source><volume>82</volume>: <fpage>276</fpage>&#x02013;<lpage>282</lpage><pub-id pub-id-type="pmid">5441760</pub-id></citation></ref><ref id="b71"><citation citation-type="journal"><name><surname>Takeda</surname><given-names>K</given-names></name>, <name><surname>Takeuchi</surname><given-names>O</given-names></name>, <name><surname>Tsujimura</surname><given-names>T</given-names></name>, <name><surname>Itami</surname><given-names>S</given-names></name>, <name><surname>Adachi</surname><given-names>O</given-names></name>, <name><surname>Kawai</surname><given-names>T</given-names></name>, <name><surname>Sanjo</surname><given-names>H</given-names></name>, <name><surname>Yoshikawa</surname><given-names>K</given-names></name>, <name><surname>Terada</surname><given-names>N</given-names></name>, <name><surname>Akira</surname><given-names>S</given-names></name> (<year>1999</year>) <article-title>Limb and skin abnormalities in mice lacking IKKalpha</article-title>. <source>Science</source><volume>284</volume>: <fpage>313</fpage>&#x02013;<lpage>316</lpage><pub-id pub-id-type="pmid">10195895</pub-id></citation></ref><ref id="b72"><citation citation-type="journal"><name><surname>Tanaka</surname><given-names>M</given-names></name>, <name><surname>Fuentes</surname><given-names>ME</given-names></name>, <name><surname>Yamaguchi</surname><given-names>K</given-names></name>, <name><surname>Durnin</surname><given-names>MH</given-names></name>, <name><surname>Dalrymple</surname><given-names>SA</given-names></name>, <name><surname>Hardy</surname><given-names>KL</given-names></name>, <name><surname>Goeddel</surname><given-names>DV</given-names></name> (<year>1999</year>) <article-title>Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice</article-title>. <source>Immunity</source><volume>10</volume>: <fpage>421</fpage>&#x02013;<lpage>429</lpage><pub-id pub-id-type="pmid">10229185</pub-id></citation></ref><ref id="b73"><citation citation-type="journal"><name><surname>ten Dijke</surname><given-names>P</given-names></name>, <name><surname>Hill</surname><given-names>CS</given-names></name> (<year>2004</year>) <article-title>New insights into TGF-beta&#x02013;Smad signalling</article-title>. <source>Trends Biochem Sci</source><volume>29</volume>: <fpage>265</fpage>&#x02013;<lpage>273</lpage><pub-id pub-id-type="pmid">15130563</pub-id></citation></ref><ref id="b74"><citation citation-type="journal"><name><surname>Vastrik</surname><given-names>I</given-names></name>, <name><surname>Kaipainen</surname><given-names>A</given-names></name>, <name><surname>Penttila</surname><given-names>TL</given-names></name>, <name><surname>Lymboussakis</surname><given-names>A</given-names></name>, <name><surname>Alitalo</surname><given-names>R</given-names></name>, <name><surname>Parvinen</surname><given-names>M</given-names></name>, <name><surname>Alitalo</surname><given-names>K</given-names></name> (<year>1995</year>) <article-title>Expression of the mad gene during cell differentiation <italic>in vivo</italic> and its inhibition of cell growth <italic>in vitro</italic></article-title>. <source>J Cell Biol</source><volume>128</volume>: <fpage>1197</fpage>&#x02013;<lpage>1208</lpage><pub-id pub-id-type="pmid">7896882</pub-id></citation></ref><ref id="b75"><citation citation-type="journal"><name><surname>Waldrip</surname><given-names>WR</given-names></name>, <name><surname>Bikoff</surname><given-names>EK</given-names></name>, <name><surname>Hoodless</surname><given-names>PA</given-names></name>, <name><surname>Wrana</surname><given-names>JL</given-names></name>, <name><surname>Robertson</surname><given-names>EJ</given-names></name> (<year>1998</year>) <article-title>Smad2 signaling in extraembryonic tissues determines anterior&#x02013;posterior polarity of the early mouse embryo</article-title>. <source>Cell</source><volume>92</volume>: <fpage>797</fpage>&#x02013;<lpage>808</lpage><pub-id pub-id-type="pmid">9529255</pub-id></citation></ref><ref id="b76"><citation citation-type="journal"><name><surname>Watt</surname><given-names>FM</given-names></name>, <name><surname>Frye</surname><given-names>M</given-names></name>, <name><surname>Benitah</surname><given-names>SA</given-names></name> (<year>2008</year>) <article-title>MYC in mammalian epidermis: how can an oncogene stimulate differentiation?</article-title><source>Nat Rev Cancer</source><volume>8</volume>: <fpage>234</fpage>&#x02013;<lpage>242</lpage><pub-id pub-id-type="pmid">18292777</pub-id></citation></ref><ref id="b77"><citation citation-type="journal"><name><surname>Weinstein</surname><given-names>M</given-names></name>, <name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>C</given-names></name>, <name><surname>Xu</surname><given-names>X</given-names></name>, <name><surname>Gotay</surname><given-names>J</given-names></name>, <name><surname>Deng</surname><given-names>CX</given-names></name> (<year>1998</year>) <article-title>Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2</article-title>. <source>Proc Natl Acad Sci USA</source><volume>95</volume>: <fpage>9378</fpage>&#x02013;<lpage>9383</lpage><pub-id pub-id-type="pmid">9689088</pub-id></citation></ref><ref id="b78"><citation citation-type="journal"><name><surname>Weiss</surname><given-names>LW</given-names></name>, <name><surname>Zelickson</surname><given-names>AS</given-names></name> (<year>1975</year>) <article-title>Embryology of the epidermis: ultrastructural aspects. III. Maturation and primary appearance of dendritic cells in the mouse with mammalian comparisons</article-title>. <source>Acta Derm Venereol</source><volume>55</volume>: <fpage>431</fpage>&#x02013;<lpage>442</lpage><pub-id pub-id-type="pmid">55035</pub-id></citation></ref><ref id="b79"><citation citation-type="journal"><name><surname>Werner</surname><given-names>S</given-names></name>, <name><surname>Beer</surname><given-names>HD</given-names></name>, <name><surname>Mauch</surname><given-names>C</given-names></name>, <name><surname>Luscher</surname><given-names>B</given-names></name>, <name><surname>Werner</surname><given-names>S</given-names></name> (<year>2001</year>) <article-title>The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis</article-title>. <source>Oncogene</source><volume>20</volume>: <fpage>7494</fpage>&#x02013;<lpage>7504</lpage><pub-id pub-id-type="pmid">11709721</pub-id></citation></ref><ref id="b80"><citation citation-type="journal"><name><surname>Wessells</surname><given-names>NK</given-names></name> (<year>1977</year>) <source>Tissue Interaction and Development</source>. Menlo Park, CA: Benjamin/Cummings</citation></ref><ref id="b81"><citation citation-type="journal"><name><surname>Woronicz</surname><given-names>JD</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>, <name><surname>Cao</surname><given-names>Z</given-names></name>, <name><surname>Rothe</surname><given-names>M</given-names></name>, <name><surname>Goeddel</surname><given-names>DV</given-names></name> (<year>1997</year>) <article-title>IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK</article-title>. <source>Science</source><volume>278</volume>: <fpage>866</fpage>&#x02013;<lpage>869</lpage><pub-id pub-id-type="pmid">9346485</pub-id></citation></ref><ref id="b82"><citation citation-type="journal"><name><surname>Yamaoka</surname><given-names>S</given-names></name>, <name><surname>Courtois</surname><given-names>G</given-names></name>, <name><surname>Bessia</surname><given-names>C</given-names></name>, <name><surname>Whiteside</surname><given-names>ST</given-names></name>, <name><surname>Weil</surname><given-names>R</given-names></name>, <name><surname>Agou</surname><given-names>F</given-names></name>, <name><surname>Kirk</surname><given-names>HE</given-names></name>, <name><surname>Kay</surname><given-names>RJ</given-names></name>, <name><surname>Israel</surname><given-names>A</given-names></name> (<year>1998</year>) <article-title>Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation</article-title>. <source>Cell</source><volume>93</volume>: <fpage>1231</fpage>&#x02013;<lpage>1240</lpage><pub-id pub-id-type="pmid">9657155</pub-id></citation></ref><ref id="b83"><citation citation-type="journal"><name><surname>Yang</surname><given-names>L</given-names></name>, <name><surname>Mao</surname><given-names>C</given-names></name>, <name><surname>Teng</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>W</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Cheng</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <name><surname>Han</surname><given-names>X</given-names></name>, <name><surname>Xia</surname><given-names>Z</given-names></name>, <name><surname>Deng</surname><given-names>H</given-names></name>, <name><surname>Yang</surname><given-names>X</given-names></name> (<year>2005</year>) <article-title>Targeted disruption of Smad4 in mouse epidermis results in failure of hair follicle cycling and formation of skin tumors</article-title>. <source>Cancer Res</source><volume>65</volume>: <fpage>8671</fpage>&#x02013;<lpage>8678</lpage><pub-id pub-id-type="pmid">16204035</pub-id></citation></ref><ref id="b84"><citation citation-type="journal"><name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>Letterio</surname><given-names>JJ</given-names></name>, <name><surname>Lechleider</surname><given-names>RJ</given-names></name>, <name><surname>Chen</surname><given-names>L</given-names></name>, <name><surname>Hayman</surname><given-names>R</given-names></name>, <name><surname>Gu</surname><given-names>H</given-names></name>, <name><surname>Roberts</surname><given-names>AB</given-names></name>, <name><surname>Deng</surname><given-names>C</given-names></name> (<year>1999</year>) <article-title>Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta</article-title>. <source>EMBO J</source><volume>18</volume>: <fpage>1280</fpage>&#x02013;<lpage>1291</lpage><pub-id pub-id-type="pmid">10064594</pub-id></citation></ref><ref id="b85"><citation citation-type="journal"><name><surname>Yoshida</surname><given-names>K</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <name><surname>Karin</surname><given-names>M</given-names></name> (<year>2000</year>) <article-title>IkappaB kinase alpha is essential for development of the mammalian cornea and conjunctiva</article-title>. <source>Invest Ophthalmol Vis Sci</source><volume>41</volume>: <fpage>3665</fpage>&#x02013;<lpage>3669</lpage><pub-id pub-id-type="pmid">11053261</pub-id></citation></ref><ref id="b86"><citation citation-type="journal"><name><surname>Zandi</surname><given-names>E</given-names></name>, <name><surname>Rothwarf</surname><given-names>DM</given-names></name>, <name><surname>Delhase</surname><given-names>M</given-names></name>, <name><surname>Hayakawa</surname><given-names>M</given-names></name>, <name><surname>Karin</surname><given-names>M</given-names></name> (<year>1997</year>) <article-title>The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation</article-title>. <source>Cell</source><volume>91</volume>: <fpage>243</fpage>&#x02013;<lpage>252</lpage><pub-id pub-id-type="pmid">9346241</pub-id></citation></ref><ref id="b87"><citation citation-type="journal"><name><surname>Zhang</surname><given-names>JY</given-names></name>, <name><surname>Green</surname><given-names>CL</given-names></name>, <name><surname>Tao</surname><given-names>S</given-names></name>, <name><surname>Khavari</surname><given-names>PA</given-names></name> (<year>2004</year>) <article-title>NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK</article-title>. <source>Genes Dev</source><volume>18</volume>: <fpage>17</fpage>&#x02013;<lpage>22</lpage><pub-id pub-id-type="pmid">14724177</pub-id></citation></ref><ref id="b88"><citation citation-type="journal"><name><surname>Zhu</surname><given-names>F</given-names></name>, <name><surname>Xia</surname><given-names>X</given-names></name>, <name><surname>Liu</surname><given-names>B</given-names></name>, <name><surname>Shen</surname><given-names>J</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <name><surname>Person</surname><given-names>M</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name> (<year>2007</year>) <article-title>IKKalpha shields 14-3-3sigma, a G(2)/M cell cycle checkpoint gene, from hypermethylation, preventing its silencing</article-title>. <source>Mol Cell</source><volume>27</volume>: <fpage>214</fpage>&#x02013;<lpage>227</lpage><pub-id pub-id-type="pmid">17643371</pub-id></citation></ref><ref id="b89"><citation citation-type="journal"><name><surname>Zhu</surname><given-names>Y</given-names></name>, <name><surname>Richardson</surname><given-names>JA</given-names></name>, <name><surname>Parada</surname><given-names>LF</given-names></name>, <name><surname>Graff</surname><given-names>JM</given-names></name> (<year>1998</year>) <article-title>Smad3 mutant mice develop metastatic colorectal cancer</article-title>. <source>Cell</source><volume>94</volume>: <fpage>703</fpage>&#x02013;<lpage>714</lpage><pub-id pub-id-type="pmid">9753318</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="f1"><label>Figure 1</label><caption><p>Macroscopical presentation of WT and <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> mice.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emboj2008196f1"/></fig><fig id="f2"><label>Figure 2</label><caption><p>(<bold>A</bold>) Haematoxylin and eosin staining of skin sections from WT and <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> mice. (<bold>B</bold>) Schematic representation of normal and <italic>Ikk</italic>&#x003b1;-deficient epidermis with expression profile of molecular markers of proliferation and differentiation (BL: basal layer; SP: spinous layer; GR: granular layer; SC: <italic>stratum corneum</italic>; hf: hair follicle; de: dermis; magnification &#x000d7; 100 in (A)).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emboj2008196f2"/></fig><fig id="f3"><label>Figure 3</label><caption><p>Schematic representation of epidermal development stages. We propose that the main function of IKK&#x003b1; is to induce cell cycle exit of intermediate keratinocytes when they mature into spinous cells.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emboj2008196f3"/></fig><fig id="f4"><label>Figure 4</label><caption><p>TGF&#x003b2;-related signalling pathway controlling Myc activity in keratinocytes. The IKK&#x003b1;&#x02013;Smad2/3 axis induces <italic>Mad1</italic> and <italic>Ovol 1</italic> expression on TGF&#x003b2; stimulation. These proteins may inhibit the activity and expression of Myc, inducing in turn keratinocyte cycle exit and differentiation. Interestingly, a TGF&#x003b2;&#x02013;Smad3/4 signalling pathway, which is not associated with IKK&#x003b1;, but functions in cooperation with E2F4/5 transcription factors, has also been shown to negatively control <italic>c-Myc</italic> expression in keratinocytes (<xref ref-type="bibr" rid="b4">Chen <italic>et al</italic>, 2002</xref>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emboj2008196f4"/></fig><fig id="f5"><label>Figure 5</label><caption><p>Mad1 expression is not induced by kDIF-mediated keratinocyte differentiation. Conditioned medium from WT keratinocytes, which contains kDIF as shown earlier (<xref ref-type="bibr" rid="b29">Hu <italic>et al</italic>, 2001</xref>), failed to induce Mad1 expression in <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> keratinocytes while leading to keratinocyte differentiation as indicated by filaggrin expression. Only the re-expression of IKK&#x003b1; in <italic>Ikk</italic>&#x003b1;<sup>&#x02013;/&#x02013;</sup> keratinocytes infected with adenovirus encoding this protein (Ad-IKK&#x003b1;) induces Mad1 expression.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emboj2008196f5"/></fig><fig id="f6"><label>Figure 6</label><caption><p>(<bold>A</bold>) In the canonical TGF&#x003b2; signalling pathway, ligands signal through type I and II transmembrane protein kinase receptors. After TGF&#x003b2; binding, type II receptor recruits and phosphorylates type I receptor, which in turn activates R-Smads. Phosphorylated R-Smads oligomerize with the co-Smad Smad4 and accumulate in the nucleus where they interact with DNA and transcription factors to regulate the expression of target genes. (<bold>B</bold>) During epidermal terminal differentiation, TGF&#x003b2;1 stimulation of keratinocytes induces the formation of a complex between activated Smad2/3 and IKK&#x003b1;. This complex accumulates in keratinocyte nuclei independently of the presence of Smad4 and controls the transcriptional activation of <italic>Mad1</italic> and <italic>Ovol1</italic> probably with the cooperation of other transcription factors such as IRF6. The Smad4-independent TGF&#x003b2;&#x02013;Smad2/3&#x02013;IKK&#x003b1; axis is required for cell cycle exit and induction of terminal differentiation of keratinocytes.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emboj2008196f6"/></fig></floats-wrap></article> 